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ABSTRACT 
 
Sensing and Separating Biomolecules at Biointerfaces. (May 2009) 
Hyunsook Jung, B.S., Hanyang University; M.S., Korea Advanced Institute of Science 
and Technology 
Chair of Advisory Committee: Dr. Paul S. Cremer 
 
Ligand-receptor interactions are ubiquitous on cell membranes. Indeed, many 
important physiological functions primarily involve such interactions. These include cell 
signaling, pathogen binding, trafficking of lymphocytes, and the immune response.1-4  
Therefore, studying ligand-receptor interactions at appropriate model membrane is of 
importance for both proper understanding of biological functions and applications to 
biosensors and bioseparations.  
Supported lipid bilayers are composed of the same lipid molecules found in the 
plasma cell membranes of living cells and possess the same two-dimensional fluidity as 
cell membranes, making them capable of mimicking the cell surface. Moreover, 
supported lipid bilayer-based in vitro assays are appealing because they require only 
very small sample volumes and they are suitable for multiplexing and high-throughput 
screening. 
Recently, our laboratory has combined supported lipid bilayer-coated 
microfluidic platforms with total internal reflection fluorescence microscopy to obtain 
equilibrium dissociation constant data for protein-ligand interactions. Using this method, 
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it was found that equilibrium dissociation constants of antibody-ligand interactions at 
lipid membrane interfaces can be strongly affected by ligand lipophilicity and linker 
length/structure. These results are described in Chapter III.  
Monitoring protein-ligand interactions is routinely performed by fluorescently 
labeling the proteins of interest. Protein labeling can, however, interfere with detection 
measurements and be highly inconvenient to employ.  To solve these problems, a simple 
and highly sensitive technique for detection of protein-ligand binding at biointerfaces 
has been developed. The method is based upon modulation of the interfacial pH when 
the protein binds. This change is detected by pH-sensitive fluorescent dye molecules 
embedded into the biointerface. The dye fluoresces strongly in the protonated state but 
becomes inactive upon deprotonation. These results are demonstrated in Chapter IV. 
Finally, the study of supported lipid bilayer-based electrophoresis is described in 
Chapter V. Bilayer electrophoresis is an attractive alternative to gel electrophoresis for 
the separation of membrane components such as lipids and membrane proteins because 
it is run in native-like environments and avoids exposing the analytes of interest to harsh 
chemicals. In this study, lipid rafts of varying size were used as separation matrices to 
separate two similar lipids with different alkyl chains. Lipid rafts of varying size were 
formed by a process controlled by varying treatment of the solid substrate. Depending on 
which method was employed, the results showed that lipid raft size could be modulated 
over five orders of magnitude. Moreover, it was found that the electrophoretic separation 
of the two lipid components depended on the size of rafts in the bilayer matrix. 
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CHAPTER I 
INTRODUCTION 
 
Objective 
 Protein-ligand interactions are ubiquitous on cell membranes. Indeed, many 
important physiological functions primarily involve such protein-ligand interactions.  
These include cell signaling, pathogen binding, trafficking of lymphocytes, and the 
immune response (Figure 1.1).1-4 Cell membranes’ two-dimensional fluidity enables a 
great variety ligand-receptor binding processes to occur. Multivalent binding typically 
results in the reorganization of membrane-linked components. Many inhibitory drugs 
function by disrupting these interactions, especially by binding to proteins within the 
membrane.5,6 Therefore, understanding the thermodynamics of binding as a function of 
membrane chemistry should provide critical insight into biological recognition and may 
lead to strategies for improved drug design such as the inhibition of viral entry or the 
termination of cancer metastasis. A proper understanding of ligand-receptor interactions 
will also be of great importance in the development and application of biosensors 
devices that exploit these interactions.  
 
 
 
 
____________    
This dissertation follows the style of the Journal of the American Chemical Society. 
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Figure 1.1.  Schematic illustration of protein-ligand interactions on a cell membrane. 
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Techniques for monitoring ligand-receptor interactions are vital to a wide 
number of fields ranging from biotechnology to fundamental cell biology. Such 
measurements are often made by fluorescently labeling the proteins and nucleotides of 
interest. Indeed, fluorescent tags have become a ubiquitous tool for detecting protein-
ligand interactions.7 Labels can, however, interfere with the detection process and be  
extremely cumbersome to implement with real-time sensor devices.8 This has been a 
major driving force behind the creation of assays that can detect biological analytes 
without labeling them (i.e. label-free detection). Methods for label-free detection include 
the use of liquid crystalline phase transitions,9,10 colloidal particle imaging,11 
semiconductor nanowire conductivity,12-14 quartz crystal microbalance (QCM) 
measurements,15-17 and surface plasmon resonance (SPR) spectroscopy.18-20 These 
techniques, however, are not always easy to employ, can give a nonlinear response to the 
analyte, require specialized equipment, and/or suffer from poor sensitivity in comparison 
with fluorescence-based measurements.21  
We wish to develop a simple label free assay that could be run in imaging mode 
for multiplexed data collection while still retaining very high sensitivity. Moreover, the 
method should be simple to use and compatible with standard laboratory equipment such 
as a fluorescence microscope or plate reader. Thus, it should not require the purchase of 
an additional dedicated instrument or specialized assay platforms (e.g. metal coated 
chips). Specifically, we are interested in developing assays with the high sensitivity of 
fluorescence techniques, but without labeling the target analyte with a fluorophore. 
surface. These dyes should work as the sensor elements upon specific protein binding.  
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Instead, we are interested in directly embedding a fluorescent dyes onto a 
substrate.  This could be achieved if the substrate-bound dye’s fluorescence would be 
strongly enhanced by a specific binding event. Such an idea would therefore combine 
the best advantages of label-free detection with fluorescence measurements. 
Up to 30 % of the open reading frames in an organism’s genome encode for 
membrane proteins, yet these species remain strongly underrepresented in many state-of-
the-art separation assays. A key aspect of our work is to move away from the agarose 
and acrylamide gels that are typically used in chromatographic processes. Instead, we 
employ a planar supported phospholipid bilayer (SLB) platform that allows proteins, 
including transmembrane species, to reside in a native-like environment while 
undergoing electrophoretic separation. In particular, we introduce lipid rafts into 
supported lipid bilayers as separation media. Using these rafts-containing bilayers as 
separation matrices, we wish to demonstrate the separation of two similar membrane-
anchored lipid components by electrophoresis: 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(cap biotinyl) (biotin-DPPE) and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(cap biotinyl) (biotin-DOPE). 
 
Fluid-supported lipid bilayers 
Planar supported bilayers are composed of the same lipid molecules found in the 
plasma membranes of living cells. Moreover, they possess the same two-dimensional 
fluidity as cell membranes,22 and are capable of mimicking the lateral rearrangements 
that take place in vivo on the cell surface.23 It is known that a thin water layer 
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 (approximately 0.5-1.5 nm in thickness) generally resides between the lower leaflet of a 
supported bilayer and the underlying substrate (Figure 1.2). This enables individual lipid 
molecules to facilely translate along the surface.24 Therefore, several ligand molecules 
can bind to a single protein with multiple binding sites simply by undergoing two-
dimensional arrangements (Figure 1.3). Since a wide variety of lipid-conjugated ligands 
can be incorporated into the membrane, it is possible to study the effects on their specific 
chemistry and presentation on multivalent binding in a highly controlled manner. Results 
for several different hapten-antibody and ganglioside toxin interactions are provided 
below. The results demonstrate that ligand presentation is far more important than ligand 
density in determining the overall protein affinity for the membrane surface.  
 
High-throughput microfluidic devices 
Exploiting microfluidic devices for the quantitative investigation of multivalent 
ligand-receptor interactions in lipid membranes was first established by our laboratory. 
25 Traditional binding measurements had previously been done using a standard flow cell 
geometry.26 Such experiments usually required long periods of time to make sequential 
binding measurements as well as large sample volumes of precious protein solutions. 
Consequently, limited information about ligand-receptor interactions could be abstracted 
from a given set of measurements. By contrast, microfluidic platforms provided a high 
throughput/low sample volume approach to such measurements. Moreover, binding data 
at multiple protein concentrations can be collected simultaneously. Therefore, the 
methods often avoid several sources of noise associated with temporal variations in 
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Figure 1.2.  Schematic illustration of a supported lipid bilayer on a planar solid 
substrate. The underlying surface is hydrophilic and typically made of glass, quartz, and 
mica. Approximately 1-2 nm of water reside between the lower leaflet of the bilayer and 
the underlying substrate. Therefore, this model system is known to conserve many of the 
properties of native cell membranes such as a two dimensional fluidity. 
 7
Glass Substrate Glass Substrate  
 
Figure 1.3.  Schematic illustration of a fluid supported lipid bilayer facilitating a 
bivalent ligand-receptor binding event. The ligand (in green) undergoes lateral 
rearrangement within the fluid lipid bilayer to bind to an antibody (in orange) in two 
consecutive steps.  
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illumination intensities from an arc lamp source as well as detector drift. 
The typical set-up employed in our laboratory for ligand-receptor binding studies 
is illustrated in Figure 1.4a. As can be seen, the heart of the device consists of a 
polydimethylsiloxane (PDMS)/glass multi-channel microfluidic device. The PDMS 
mold is patterned via standard soft lithographic techniques.27 Lipids are coated on the 
walls and floor of this platform via the vesicle fusion method.28 Next, a completed 
PDMS/glass device is situated on top of a dove prism. A drop of immersion oil is 
introduced between the device and the prism to allow total internal reflection 
fluorescence microscopy (TIRFM) measurements to be made.29  
Dye-labeled protein solutions are then simultaneously flowed through each 
channel at varying concentrations. The evanescent field generated at the liquid/solid 
interface excites fluorescent molecules adjacent to the interface with high specificity 
(Figure 1.4b).25,30,31 The amount of adsorbed protein within a given channel is found to 
be linearly proportional to the intensity of fluorescence 26 under the conditions which are 
employed. Additional contributions from labeled proteins in the near surface bulk 
volume can be subtracted away by performing control experiments with no ligands in the 
membrane.32 A plot of fluorescence intensity vs. bulk protein concentration from a 
typical experiment is provide in Figure 1.4c. A line profile of these data can then be used 
to construct a standard binding isotherm from which a KD values can be abstracted 
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 (Figure 1.4d). Since the binding of proteins from aqueous solution at many 
concentrations is monitored simultaneously, it is possible to watch the entire binding 
curve evolve. Equilibrium is typically established more quickly at the highest protein 
concentrations. On the other hand, the system takes longer to reach equilibrium at lower 
bulk protein concentrations because of diffusion limits to the surface. Protein solution is 
constantly flowed through the device until the fluorescence signal from the entire 
TIRFM area remains unchanged. This can take several hours or more for pM 
concentrations of protein solution. 
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Figure 1.4.  (a) Schematic of the experimental setup for performing ligand-receptor 
binding measurements in microfluidic devices. (b) Schematic representation of proteins 
adsorbed on the supported bilayer surface. (c) Total internal reflection fluorescence 
micrograph of a working device. (d) A one-shot binding curve obtained from the data in 
(c).   
 11
CHAPTER II 
EXPERIMENTAL SECTION 
 
Materials 
Biotin-4-fluorescein (B4F), Texas Red DHPE, and Alexa Fluor-594 labeling kit  
was purchased from Invitrogen (Eugene, OR). ω-Hydroxyl α-amino polyethylene glycol 
was obtained from Jenkem Technology USA (Plano, TX). Affinity purified polyclonal 
anti-biotin IgG from goat (lot # 15501, Rockland, Gilbertsville, PA) and polyclonal anti-
DNP IgG from goat (lot # A150-117A-1, Axxora, San Diego, CA) were used as 
received. Rabbit polyclonal anti-biotin antibody came from Rockland (Gilbertsville, PA). 
Cholera toxin B from Vibrio cholerae was purchased from Sigma-Aldrich (St. Louis, 
MO). Streptavidin was purchased form Rockland (Gilbertsville). 
1-Palmitoyl-2-oleoyl-sn-glycero-3-phophocholine (POPC), 1, 2-dipalmitoyl-sn -
glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt) (biotin-cap-PE or biotin-
DPPE), 1, 2-dioleoyl-sn -glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt) 
(biotin-DOPE), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC), ganglioside GM1 (brain, ovine-ammonium salt), 
cholesterol, and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[6-[(2,4-
dinitrophenyl)amino]c-aproyl] (DNP-cap-PE) were purchased from Avanti Polar Lipids 
(Alabaster, AL).   1,2 – dioleoyl – sn – glycerol - 3-phosphoethanolamine-N-
[methoxy(poly(ethylene glycol)-5000)]  (ammonium salt) (PEG5000-PE),1,2-distearoly-
sn-glycero-3-phosphoethanolamine-N-[methoxy(poly(ethylene glycol) - 2000)] 
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(ammonium salt) (PEG2000-PE),  1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[biotinyl(polyethylene glycol)-2000] (ammonium salt) (biotin-PEG2000-PE),  1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) 
(ammonium salt) (NBD-PE), and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[amino(polyethylene glycol)-2000] (ammonium salt) (NH2-PEG2000-PE) were also 
obtained from Avanti Polar Lipids. Three additional molecules needed for these studies, 
DNP (5-fluorescein) (D5F), DNP-PEG2000-PE, and DNP-PEG2000 were not commercially 
available, but could be easily synthesized as described below. 
Thin layer chromatography (TLC) was carried out using precoated plates made 
of silica gel with a pore size of 60 Å and a layer thickness of 250 μm (Silica Gel 60 F254, 
EMD Chemicals Inc., Germany). Purified water was produced from a NANOpure 
Ultrapure Water System (18.2 MΩ·cm, Barnstead, Dubuque, IA). Glass coverslips (25 × 
25 mm, No. 2, Corning Inc.) were used as solid supports for the bilayers. 
Polydimethylsiloxane (PDMS, Dow Corning Sylgard Silicone Elastomer-184) was 
obtained from Krayden, Inc (El Paso, TX). Sodium phosphates and NaCl were obtained 
from Sigma-Aldrich (St. Louis, MO). Ammonium fluoride (NH4F) was obtained from 
Alfa Aesar (Ward Hill, MA) and hydrofluoric acid (HF) was purchased from EMD.  
Platinum wire with a diameter of 0.25 mm was purchased from Alfa Aesar. All 
chemicals were used as received without further purification. 
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Synthesis of small organic ligand molecules 
Synthesis of DNP (5-fluorescein) (D5F). To prepare D5F, 5-carboxyfluorescein 
succinimidyl ester (7.1 mg in dimethyl sulfoxide (DMSO)) was slowly added to a 
solution of N-(2, 4-dinitrophenyl)-cadaverine hydrochloride (4.8 mg) in 4.87 mL of 
sodium bicarbonate buffer (100 mM, pH 8.3). It should be noted that this represents a 
molar ratio of 1.0 to 1.1. An orange product formed immediately. The reaction was 
allowed to proceed for 1 h at room temperature in the dark under constant stirring. The 
reaction mixture was concentrated to an oil on a rotary evaporator and then redissolved 
in a CH3CN/CH3OH/H2O mixture (5:4:1 by volume) for silica gel chromatography. The 
product-containing fraction was further purified by preparative reversed phase high-
performance liquid chromatography (HPLC) and characterized by time of flight mass 
spectrometry (TOF-MS). The molecular mass was found to be 626.1 Da as expected. 
Preparation of vesicles containing DNP-PEG2000-PE. Small unilamellar 
vesicles (SUVs) composed of NH2-PEG2000-PE (1 mol %)/PEG2000-PE (0, 4, or 9 mol 
%)/POPC (99, 95, or 90 mol %) as well as NH2-PEG2000-PE (5 mol %)/POPC (95 mol 
%) were mixed with an excess of 6-(2, 4-dinitrophenyl)aminohexanoic acid, 
succinimidyl ester (DNP-X, SE, Invitrogen, Eugene, OR) in phosphate buffered saline 
(PBS). DNP-X was only sparingly soluble in the PBS solution so 100 µL of DMSO was 
added to the 500 µL aqueous solution to improve solubility. This solution was stirred for 
4 h at room temperature. It should be noted that the PBS solution consisted of 20 mM 
Na2HPO4 and 150 mM NaCl. The pH value was adjusted to 7.2 by the dropwise addition 
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of NaOH. Purified water from a NANOpure Ultrapure Water System (18.2 MΩ•cm, 
Barnstead, Dubuque, IA) was employed for making all solutions. 
Product-containing SUVs were separated from unreacted DNP-X, SE by size 
exclusion chromatography using standard procedures.33 The formation of DNP-PEG2000-
PE was confirmed by matrix assisted laser desorption ionization mass spectrometry 
(MALDI-MS). The molecular mass was found to be 3051.5 Da in H+ mode. The 
unreacted NH2-PEG2000-PE peak at 2788.1 Da was also found. This is not surprising 
because half the NH2-PEG2000-PE was facing inside of the vesicles during the reaction 
and should not be available. In fact, approximately 50 mol % of the NH2-PEG2000-PE 
was not conjugated to DNP. Control experiments demonstrated that NH2-PEG2000-PE did 
not bind to anti-DNP antibodies in supported membrane formats.  
The mol % of DNP-PEG2000-PE in each SUV was determined by forming 
supported bilayers with these lipids in POPC and performing quantitative binding 
measurements by introducing a saturation concentration of fluorescently labeled IgG 
molecules into the bulk phase. Such data were then directly compared to analogous 
fluorescence intensity results obtained with DNP-cap-PE in POPC at known ligand 
concentration. These results confirmed that half of the NH2-PEG2000-PE in each vesicle 
was converted to DNP-PEG2000-PE as expected.    
Synthesis of DNP-PEG2000. 6-(2,4-dinitrophenyl)aminohexanoic acid, 
succinimidyl ester (4.2 mg in DMSO) was slowly mixed with a solution of ω-hydroxyl 
α-amino polyethylene glycol (16 mg) in sodium bicarbonate buffer (100 mM, pH 8.3). 
The molar ratio was 1.2 to 1.0. The reaction was completed after 3 h under constant 
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stirring. A yellow solid product was purified by silica gel chromatography and then 
characterized by MALDI-MS. The molecular mass was found to be 2329. 6 Da in H+ 
mode. 
 
Preparation of small unilamellar vesicles (SUVs) 
Lipids in the desired composition ratio were introduced into a glass vial in 
chloroform. The solvent was removed by passing a gentle stream of dry nitrogen over 
the solution. The resulting film was further dried under vacuum for 3 h. The film was 
then hydrated in a 10 mM phosphate buffered saline (PBS) solution containing 150 mM 
NaCl. After suspension of the lipid mixture, it was subjected to 10 freeze-thaw cycles 
and then extruded 10 times through two stacked polycarbonate membranes (Whatman) 
with 100 nm pores. The resulting SUVs prepared by this procedure were 70 ± 10 nm in 
diameter as determined by dynamic light scattering (Brookhaven Instruments 90Plus 
Particle Size Analyzer). The final concentration of the lipid solutions employed for 
vesicle fusion experiments was 0.5 mg/mL. The vesicles were kept at 4 °C before use. 
A side-by-side comparison of the lipid composition from vesicles and the 
subsequently formed lipid bilayer was made to confirm that they had identical 
composition. This was done by MALDI-MS. The results showed that the two 
compositions in bulk were the same within experimental error. Additional controls were 
performed to compare the ratio of intensities of dye (Alexa Fluor 594)-labeled PEG 
lipids33 and NBD-PE in surface adsorbed vesicles and SLBs. The relative intensity ratio 
of the two dyes was found to be similar. Thus, it was assumed herein that the 
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concentration of hapten in the upper leaflet of the bilayer was similar to its concentration 
in vesicles.  
 
Fabrication of microfluidic devices 
Seven or nine-channel microfluidic devices (130 μm wide, 15 μm deep, and 
separated by 160 μm spacing) were formed by conventional soft lithographic methods.34 
First, glass substrates (soda-lime glass slides, Corning) were spin-coated with photoresist 
(Shipley 1827) and then exposed to UV light through a Kodak technical pan film 
photomask containing the appropriate image. After the substrates were treated in 
developing solution and baked overnight at 120°C, they were immersed in a buffered 
oxide echant (BOE) to etch the glass. The BOE solution was prepared with a 1:6 ratio 
(v/v) of 48% HF (EMD Chemicals Inc., Germany) and aqueous NH4F (200 g in 300 mL 
purified water, Alfa Aesar, Ward Hill, MA).35 The remaining photoresist was removed 
with acetone. Next, a degassed mixture of Sylgard silicone elastomer-184 and a curing 
agent (10:1 ratio (v/v)) was poured over the patterned glass substrate. The liquid PDMS 
was cured in an oven at 70 °C for 1 h and then peeled off the glass substrate. This 
elastomeric mold and a freshly cleaned glass cover slip were placed into a 25 W oxygen 
plasma for 30 s and immediately brought into contact to form the PDMS/glass device. 
The glass slides used in these experiments were cleaned in a boiling solution of ICN 7X 
(Costa Mesa, CA) and purified water (1:4 ratio (v/v)) for 30 minutes, rinsed with 
copious amounts of purified water, and dried gently under a flow of nitrogen gas. Finally, 
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the glass substrates were annealed in a kiln at 450 °C for 5 h before introduction into the 
oxygen plasma. 
 
Formation of supported lipid bilayers 
 SLBs were formed on the walls and floors of microchannels by the spontaneous 
fusion of SUVs.36 To do this, 5 μL of an SUV solution were injected into each channel 
immediately after the formation of a PDMS/glass device. The solutions were incubated 
in the channels for 10 minutes and then rinsed away with pure PBS buffer to remove 
excess vesicles. All SLBs employed in these experiments were verified to be 
homogeneous down to the optical diffraction limit under fluorescence microscopy using 
a 40× objective. This was even the case for ternary lipid mixtures such as biotin-cap-
PE/PEG5000-PE/POPC.  
 
Fluorescence anisotropy measurements 
Solution binding assays were performed by single-point fluorescence anisotropy 
measurements (Koala spectrofluorometer, ISS Inc., Urbana-Champaign, IL). Data were 
abstracted according to established procedures.37 Briefly, samples were excited with 
vertically polarized light at 490 nm with a slit width of 8 nm. Emission measurements 
were made with both vertically, IVV, and horizontally, IVH, polarized light. Note that the 
first subscript on the intensity term refers to the excitation polarization, while the second 
subscript refers to the emission polarization. The correction factor, G, was determined as 
described elsewhere.38 The fluorescence anisotropy, r, was then calculated as follows: 
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Circulating water baths maintained the samples at a constant temperature (25.0 ± 0.1 ºC). 
Background fluorescence corrections for antibody solutions were performed as well as 
PBS blanks. In all cases the control sample intensities were found to be less than 2 % of 
the B4F and D5F intensities.  
 
Total internal reflection fluorescence microscopy (TIRFM) 
 Binding measurements with labeled antibodies were performed inside 
microfluidic devices in combination with TIRFM.39 Alexa Fluor-594 tags were 
conjugated to the IgG molecules molecules using an Invitrogen labeling kit by following 
standard procedures. The labeled antibody solutions at various concentrations were 
flowed through each microchannel until the bulk fluorescence intensity from the dye-
labeled antibodies remained constant as judged by epifluorescence measurements. A 594 
nm helium-neon laser beam (4 mW, Uniphase, Manteca, CA) was projected onto the 
sample with a line generator lens (BK7 for 30°, Edmund Optics, Barrington, NJ) for 
TIRFM measurements. This created a uniform intensity profile perpendicular to the 
direction of flow of the microfluidic channels. On the other hand, the intensity of the 
beam parallel to the long axis of the channels corresponded to a Gaussian profile. The 
glass substrates for the microfluidic devices were optically coupled to a dove prism with 
index matching immersion oil (type DF, Cargille Laboratories, Ceder Grove, NJ).  
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 It should be noted that one important advantage of our microfluidic assays is that 
the binding data at all protein concentrations can be monitored simultaneously as a 
function of time. Therefore, one can monitor the binding curve’s evolution. It is typically 
observed that the lowest concentration points take the longest time to achieve their 
ultimate values. It should be further noted that antibody binding is reversible, but 
requires the presence of soluble ligand in solution to compete the antibody off the 
surface in a reasonable amount of time. This has to do with rebinding effects that have 
been studied by Thompson and coworkers.40-43  
Background subtraction measurements were performed by measuring the 
fluorescence intensity of antibodies above supported lipid membranes containing no 
hapten-conjugated lipids.39  
 
Separation of Texas Red DHPE isomers 
The two isomers of Texas Red DHPE were separated by using a slightly 
modified form of our previously published procedures.44 Briefly, small spots of the 
ortho/para mixture were made on a TLC plate from a 1 mg/mL chloroform solution. 
Next, the spotted plate was placed into a development chamber and ethanol (AAPER 
Alcohol and Chemical Co., Shelbyville, KY) was used as the eluent. Two bands were 
formed, whereby the upper band was the para isomer and the lower band was the ortho 
isomer. Each band was recovered separately from the plate by carefully scraping the 
surface with a razor blade and re-suspending the dye/silica bead mixture in methanol. 
The silica was separated from the soluble organic material by filtration. Methanol could 
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then be removed by using a rotary pump and further drying the sample under vacuum on 
a Schlenk line. TLC was rerun with a small portion of the isolated sample to confirm the 
purity of each isomer. 
 
pH titration and buffer preparation 
10 mM PBS solutions containing 150 mM NaCl were prepared at pH values 
ranging from 4.0 to 10.2 by mixing appropriate amounts of Na2HPO4, NaH2PO4, or 
Na3PO4. These pH values were chosen to locate the pKA value of ortho-Texas Red 
DHPE. The pH could be adjusted to the desired value by the dropwise addition of HCl or 
NaOH. The pH was measured with a standard glass electrode setup. Such absolute 
measurements had an error of ± 0.1 pH units associated with them. Changes in 
fluorescence, however, could be measured far more accurately. These changes in 
fluorescence intensity corresponded to relative shifts in interfacial pH as small as 0.002 
pH units when a 40× objective was employed for making the measurements. Titration 
curves for the dye molecules in SLBs were obtained by systematically changing the pH 
of the bulk solution in a stepwise fashion. Fresh buffer was continuously flowed over the 
surface until no further changes in fluorescence intensity could be observed. The quality 
and fluidity of the supported bilayers as a function of pH was confirmed by fluorescence 
recovery after photobleaching (FRAP) measurements.45 Fluorescent micrographs of 
SLBs were captured with a standard epifluorescence microscope setup (Nikon Eclipse 
E800).  
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The fluorescence titration curve of the Texas Red DHPE dye molecules was 
monitored in SLBs containing two narrow, parallel lines of bilayers with distinct dye 
chemistries. The first line contained 99.47 mol % POPC/0.50 mol % biotin-cap-
PE/~0.03 mol % ortho-Texas Red DHPE. The second line was identical, but contained 
para-Texas Red DHPE instead of the ortho isomer. The surrounding lipid matrix was a 
1:1:1 mixture of DOPC, DPPC, and cholesterol. This composition was chosen because 
diffusion of the dyes molecules from the narrow lines into the surrounding matrix was 
extremely slow. The two lines were formed sequentially by mechanically scratching the 
DOPC/DPPC/cholesterol bilayer and backfilling with the desired lipid mixture using the 
vesicle fusion method.  
The titration curve for the Texas Red DHPE dye molecules in the presence of a 
saturated anti-biotin protein monolayer on a supported membrane surface was obtained 
with the same bilayer as described above. In this case, however, a saturation 
concentration of IgG (500 nM) was first introduced into the bulk solution. Moreover, all 
fluorescence measurements as a function of pH were performed in the presence of 500 
nM bulk protein concentration to ensure that the surface remained saturated with protein.  
All experiments presented herein were conducted with 150 mM NaCl. Additional 
control experiments were performed with varying concentrations of salts up to 300 mM. 
The results showed that fluorescence changes upon protein binding were not affected 
within experimental errors when moderately high salt concentrations were present. This 
is to be expected because the Debye length is below 1 nm so long as there is at least 100 
mM NaCl in the buffer solution.46 
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Preparation of glass substrates 
Glass coverslips (25×25 mm2, #2, Corning)  were cleaned in a boiling solution of 
ICN 7X (Costa Mesa, CA) and DI water (1: 4 (v/v)) for 30 minutes, rinsed with copious 
amounts of DI water, and dried with nitrogen gas before any additional treatments. A 
buffered oxide etchant (BOE) solution was prepared by 1:6 ratios (v/v) of 48 % HF: 200 
g NH4F in 300 mL DI water. Baked glass substrate: cleaned glass substrates were 
annealed in a kiln at 450 °C for 5 h to yield flat surfaces with a typical root mean square 
roughness (RMS) value of 0.31 nm over a 1 μm2 area as determined by AFM. HF-
etched substrate: baked glass substrates were gently wafted by hand in BOE solution 
for 5 or 10 minutes, washed in a 1M HCl solution for 1 minute, rinsed thoroughly with 
DI water, and dried under nitrogen gas. The RMS value of HF-etched substrate was 
found to be 0.41 nm by AFM. Piranha-etched substrate: glass substrates were cleaned 
for 5 minutes in a solution of 4:1 (v/v) concentrated sulfuric acid and 35 wt % hydrogen 
peroxide (Acros, NJ), rinsed with extensive amounts of DI water, and dried in a gentle 
stream of nitrogen. (Caution: Piranha solution is extremely hazardous and must be 
handled with care). All substrates were used immediately after treatment.  
 
Formation of lipid rafts of varying size 
Supported lipid bilayers were formed via a vesicle fusion method.47 A drop of 
vesicle solution (150 μL) consisting of DOPC/DPPC/cholesterol (1:1:1) and Texas Red 
DHPE (0.03 mol %) were placed on the appropriately treated glass substrate. A 
polydimethylsiloxane (PDMS) mold was used to confine supported lipid bilayers on 
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glass substrates. The mold was made by cross-linking PDMS between two silanized 
glass microscope slides (50×75 mm2, Corning) separated by a thin metal spacer between 
200 and 400 µm thick. After cross-linking, a rectangular hole (1×2 cm2) was cut out of 
the center of the thin elastomeric sheet using a razor blade. Vesicle solutions were 
allowed to warm to room temperature (22-25 °C) before use. Texas Red DHPE was 
incorporated into the membrane composition to visualize raft and non-raft regions after 
they were formed.  The solution was confined to a rectangular area in the center of the 
substrate by a thin PDMS wall and incubated on the substrate for 10 minutes. Excess 
vesicles were rinsed away from the surface with copious amounts of DI water. Large 
microrafts (11 μm): lipid bilayers formed on the HF-etched (10 minutes) substrate were 
heated at 50 °C for 2 h and slowly cooled back to room temperature. Medium 
microrafts (7 μm): lipid bilayers formed on the HF-etched (5 minutes) substrate were 
heated at 50 °C for 2 h and slowly cooled back to room temperature. Small microrafts 
(2 μm): lipid bilayers formed on the piranha-etched substrate were heated at 50 °C for 1 
h followed by cooling to room temperature. Nanorafts (98 nm): lipid bilayers formed 
on the baked substrate were heated for 1 h and cooled down to room temperature. 
Nanorafts (42 nm): lipid bilayers formed on the baked substrate were heated for 25 
minutes and cooled down to room temperature. No observable rafts: lipid bilayers were 
formed on the baked substrate and no heat treatment was applied. Raft and non-raft 
regions in supported bilayers were characterized by fluorescence microscopy and AFM. 
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Partition coefficients (Kpi) of molecules into rafts 
To quantify the partitioning of two biotin lipids (biotin-DPPE and biotin-DOPE) 
between raft and non-raft regions, rafts of 7 µm size were formed by using the following 
lipid composition: DOPC/DPPC/cholesterol (1:1:1) containing biotin-DPPE (1 mol %) 
or biotin-DOPE (1 mol %), respectively. Raft and non-raft regions were then visualized 
by staining those lipids with Alexa Fluor 594-labeled streptavidin (0.5 µM). The 
intensities were corrected for dark counts and stray light by subtracting the average 
background intensity measured for bare glass. The average fluorescence intensities of 
areas corresponding to these regions were calculated from 16-bit digitized CCD 
fluorescence micrographs. The partition coefficient (Kpi) was defined as Kpi = Ir/In, 
where Ir and In were the background-corrected average fluorescence intensities measured 
in the raft and non-raft regions, respectively. The quantum efficiencies of the 
fluorophores attached to the probe molecules (Alexa Fluor-594 in this case) and the 
matrix lipid densities are assumed to be identical for both raft and non-raft regions.  
 
Epifluorescence microscopy 
An inverted epifluorescence Nikon Eclipse TE2000-U microscope with a 10× air 
objective (N.A. = 0.45) was used for FRAP studies. Laser radiation from a 2.5 W mixed 
gas Ar+/K+ laser (Stabilite 2018, Spectra Physics) was used to bleach a small spot (14 
μm in diameter) in the supported bilayer sample.  
Fluorescence imaging studies were performed with a Nikon Eclipse E800 
fluorescence microscope (Tokyo, Japan) equipped with a MicroMax 1024 CCD camera 
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(Princeton Instruments), a Texas Red filter set (Chroma Technology, Bellows Falls, VT) 
and either a 4× air (N.A. = 0.13) or a 10× air (N.A. = 0.45) objective. An X-Cite 120 arc 
lamp (EXFO) was used as the light source for all experiments and all images were 
processed with MetaMorph software (Universal Imaging). Data acquisition for the limit 
of detection experiments was also performed in epifluorescence mode. In this case, a 
40× oil immersion objective (N.A. = 1.30) was used to monitor the fluorescence 
intensity. 
 
Atomic force microscopy (AFM) 
  AFM imaging of supported lipid bilayers containing nanorafts and no rafts was 
performed as previously described elsewhere.34 The bilayer-coated glass in AFM liquid 
sample cell were mounted on a J-type scanner of a nanoscope IIIa Multimode SPM 
(Digital Instruments, Santa Barbara, CA) under ambient conditions. The experimental 
conditions of the bilayers were identical to those used in fluorescence microscopy. 
Height images were acquired in fluid contact mode at a scan rate of 2.0 Hz using oxide-
sharpened DNP-S1 silicon nitride probes (spring constant: 0.06 N/m, Veeco Probes, 
Santa Barbara, CA). Rafts were identified from non-rafts when the feature height 
exceeded ~ 0.7-1.1 nm above the membrane background.48 All AFM images shown in 
this paper are flattened raw data. 
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Bilayer electrophoresis 
Matrix lipid bilayers containing rafts of varying size were prepared as described 
above. A line of bilayer substrate was then carefully removed from the matrix lipid 
bilayers using a piece of metal tweezers and washed away with copious amounts of DI 
water. This process was found not to cause any damage to the underlying substrate. 
Immediately following this step, 150 µL of vesicle solution containing the two biotin 
lipid mixtures (1 mol % biotin-DPPE and 1 mol % biotin-DOPE) were added into the 
aqueous phase above the surface. The vesicles fused to the bare portion of the substrate, 
creating a thin bilayer strip (~100 µm width) with the biotin lipid mixtures. After 
incubation for 5 minutes, the sample was thoroughly rinsed with DI water.  The DI water 
was used to avoid excessive Joule heating. A 125V/cm potential (DC) was applied 
laterally across the bilayers by placing a platinum wire electrode on each side of the 
PDMS wall with a standard regulated power supply (TCR 300, Sorensen). The current 
was monitored with a digital multimeter (177 Microvolt DMM, Keithly). Currents of 
only a few microamps or less were maintained during the application of high electric 
field strength. Electrophoresis was performed for 30 minutes.  Next, the 
electrophoretically separated biotin lipids were stained with Alexa Fluor 594-labeled 
streptavidin (0.5 µM) for 10 minutes. Excess proteins were washed away with DI water. 
Biotin lipids migrated toward the positive electrode as expected from their charge (-1). A 
microscope with a 4× objective (N.A. = 0.13) was used to maximize the field of view in 
the results.  
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CHAPTER III 
IMPACT OF HAPTEN PRESENTATION ON ANTIBODY BINDING AT LIPID 
MEMBRANE INTERFACES* 
 
Introduction 
 
Interactions which occur between proteins and ligands are ubiquitous in 
biological recognition.40,49-51 Many drug molecules function by disrupting these 
interactions, especially by binding to proteins at membrane interfaces.52,53 Curiously, the 
equilibrium dissociation constants for drugs with membrane proteins in vivo are often 
only in the micromolar range.54,55 This is the case despite the fact that many of these 
interactions are nanomolar or even picomolar when originally screened in vitro in the 
absence of a lipid bilayer. There is some evidence in the literature that the partitioning of 
drug molecules into lipid membranes occurs via lipophilic interactions.54,56,57 It certainly 
is possible that such interactions as well as interactions with the cell's glycocalix are 
responsible for suppressing KD values for drug molecules in vivo. Therefore, we wished 
to test the binding affinity of ligand-receptor interactions for model binding systems at 
membrane surfaces as well as in bulk solution to see if lipophilicity and steric effects 
could modulate the binding constants of simple antibody/antigen systems. 
 
____________    
* Reproduced with permission from “Impact of Hapten Presentation on Antibody 
Binding at Lipid Membrane Interfaces” by Jung, H., Yang, T., Lasagna, M. D., Shi, J., 
Reinhart, G. D., and Cremer, P. S. 2008. Biophys. J., 94, 3094-3103, Copyright 2008 by 
Elsevier.  
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The specific binding of antibodies with their target antigens at cell surfaces is a 
key step in immune response.58,59 The recognition of membrane-conjugated haptens by 
free protein molecules is, in contrast to solution recognition, complicated by the 
presence of the cell membrane interface.60 Previous studies have shown that binding 
between IgG molecules and antigens bound in the membrane depends upon the specific 
conditions of the experiment. For example, the McConnell group reported qualitative 
data which indicated that the binding of anti-DNP antibodies with DNP-conjugated lipid 
haptens was reduced above the chain-melting transition temperature of a lipid bilayers 
compared to the same system in the gel state.61,62 The authors suggested that the DNP 
moieties can interact with the interior of the fluid lipid bilayers. Additionally, PEG-
modified lipid membranes are believed to decrease the efficiency of the ligand-receptor 
recognition processes. Kim,63 Moore,64 and their coworkers have reported that the 
adhesion strength of ligand-protein interactions depends on the ligand accessibility 
within the PEG layer. Dori and coworkers demonstrated that cell adhesion to peptide 
ligands in a supported bilayers can be controlled by the addition of PEG-conjugated 
lipids to the membrane.65 Such effects can be desirable. In fact, PEG-conjugated 
liposome surfaces have been shown to have long circulation times in vivo.66,67 The 
extracellular PEG layer is generally believed to stabilize the liposome surface via steric 
repulsion effects.68,69      
PEG moieties can also be used to enhance binding rather than inhibit it. For 
example, target molecules are often tethered to the terminal end of a PEG chain for site 
specific liposome drug delivery.70-72 Similarly, ligands can be covalently linked to 
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flexible spacers or tethers on lipid bilayers. It is known that protein binding to ligands at 
surfaces via long, flexible polymer tethers can be more efficient than when the tether is 
very short.73-75 Such tethers may serve to orient the ligands, which could aid in the 
efficacy of antibody binding depending on the relative hydrophobicity of the linker. In 
fact, DNP and trinitorphenyl (TNP) haptens with sufficiently short or long hydrophobic 
spacers are known to be less effective for antibody binding than those with intermediate 
chain lengths.76,77 Ahlers,78 Leckband,60 and their coworkers have emphasized long, 
flexible, hydrophilic ethylene oxide linkers for improving hapten presentation at bilayer 
interfaces. 
Herein, we report that hapten presentation for binding aqueous IgG antibodies 
can be systematically manipulated depending upon the ligand’s lipophilicity, the 
presence of membrane-conjugated PEG in the membrane, and the use of PEG linkers to 
conjugate the hapten. Specifically, equilibrium dissociation constants for the biotin/anti-
biotin and DNP/anti-DNP systems were examined in bulk solution and at model 
membrane surfaces. Solution binding constants were determined by fluorescence 
anisotropy measurements.37,79,80 For surface binding assays, lipid membrane-coated 
microfluidic devices were employed in conjunction with total internal reflection 
fluorescence microscopy (TIRFM),81 a method previously established in our lab.82 
Lipid-conjugated haptens were incorporated into the supported lipid bilayers (SLBs), 
which are well-known to show specific antibody binding and retain many of the 
properties of native cell membranes.22 Such methods rapidly provide highly accurate 
thermodynamic information while consuming relatively low sample volumes.  
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Figure 2.1.  Schematic representation of antibody-hapten interactions. (a) Bulk 
solution. (b) Binding at phospholipid membrane surfaces. The hydrophilic biotin ligands 
are fully exposed to aqueous solution. By contrast, the lipophilic DNP ligands spend 
more time buried in the lipid phase. (c) Binding at PEG-coated surfaces. For the biotin 
case, the PEG lipopolymer screens the ligand. On the other hand, presenting the DNP 
ligand on the end of a PEG tether helps enhance binding. 
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The results of our experiments are summarized in Figure 2.1. It was found that 
anti-biotin and anti-DNP bind with their respective hapten moieties in bulk solution with 
nearly identical affinity (low nanomolar KD values). At a lipid membrane interface, anti-  
biotin was still found to bind to lipid-conjugated biotin with very strong affinity. By 
contrast, the equilibrium dissociation constant was greatly weakened for anti-DNP 
binding to lipid-conjugated DNP on a supported lipid bilayer. This result can be 
explained in terms of the relative lipophilicity of DNP compared with biotin. Most of 
this lost affinity could be recovered by linking the DNP moiety to the end of a PEG2000-
conjugated lipid (see Figure 2.2 for structure). On the other hand, biotin/anti-biotin 
binding could be weakened to micromolar affinity by covering the biotin-presenting 
interface under a pegylated layer. These results clearly demonstrate that interfacial 
binding affinity can be manipulated over a wide range of binding affinities simply by 
altering the nature of ligand presentation. 
 
Results 
Binding in bulk solution. In a first set of experiments, binding constants for 
antibody-hapten interactions were measured in bulk by the fluorescence anisotropy 
technique. The fraction of bound hapten, fB, was estimated as follows:83  
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Figure 2.2.  Structures of ligands. (a) B4F, (b) D5F, (c) DNP-PEG2000-PE, and (d) 
DNP-PEG2000. (a), (b), and (d) were used for solution binding measurements. (c) was 
used for surface binding measurements. 
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where r is the observed anisotropy. On the other hand, rF and rB are the anisotropies of 
the free and bound ligands, respectively. The parameter, R, was introduced to correct for 
changes in total fluorescence intensity upon complex formation.84 Its value is determined 
by the ratio of the wavelength-integrated intensity of the free, FF, and bound forms, FB, 
of the dye-conjugated antigen as can be seen in Eq. 2.1. The absorption of the samples 
was matched and kept below 0.05 to avoid inner filter effects. The values of R were 
found to be 0.68 for biotin/anti-biotin and 2.3 for DNP/anti-DNP, respectively.   
Experiments were performed with 1 nM of both B4F and D5F (see Figure 2.2 for 
structures). The antibody concentrations were varied. A Langmuir adsorption model was 
then employed to determine the apparent bulk equilibrium dissociation constant, 
KD(bulk): 
]/[]][[)( PLLPbulkK D =                                         (2.2) 
where [P], [L], and [PL] represent the concentrations of free antibody, free antigen, and 
the antibody-antigen complex, respectively. The total concentration of antigen in 
solution, [L]tot, is: 
][][][ PLLL tot +=                                          (2.3) 
From this relationship, the fractional binding, fB, of ligand to the protein should be: 
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The concentration of free antibody, [P], was calculated by subtracting the bound 
antibody concentrations from the total protein concentration.85  
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Figure 2.3.  Binding isotherms in bulk solution obtained from fluorescence anisotropy 
measurements. (a) B4F binding with anti-biotin antibody. (b) D5F binding with anti-
DNP antibody. Each data point represents the averaging of three measurements. 
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Non-specific binding as well as a correction term arising from the bound vs. free 
ligand concentrations was not taken into account. It should be noted, however, that the 
calculation is still considered to be valid in the present case because the ligand 
concentration (1 nM) did not exceed the measured KD(bulk) values.86 Moreover, non-
specific IgG adsorption on the walls of the sample holder (plastic cuvettes used) should 
be minimal because plastic rather than glass cuvettes were employed.85,87  
Figure 2.3 shows the binding isotherms for the (a) biotin/anti-biotin and (b) 
DNP/anti-DNP binding pairs. The KD(bulk) values extracted from these data are equal to  
the concentration of free antibodies in solution at which half of the B4F and D5F 
molecules are bound to their respective antibodies. At 25 ºC, KD(bulk) was found to be 
1.7 ± 0.2 nM for biotin/anti-biotin and 2.9 ± 0.1 nM for DNP/anti-DNP, respectively. 
These values are in good agreement with previous reports for each hapten/antibody 
system.88,89 The present data are also consistent with the notion that the fluorescein and 
linker moieties do not significantly influence the KD(bulk) measurements. These results 
demonstrate that the intrinsic affinity of the two antibodies for their respective antigens 
in bulk solution is nearly identical.  
Binding at lipid membrane surfaces. As with bulk binding data, a Langmuir 
adsorption model was employed for fitting data at membrane interfaces. The association 
of a free antibody in solution with an available membrane-bound hapten, Ls, led to the 
formation of a membrane-bound complex, PLs, which could be characterized by a first 
dissociation constant, KD1: 
                 ssD LPPLK ]][[][1 =                                                               (2.5) 
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A key difference between Eq. 2.2 and Eq. 2.5 is the presence of the subscript, s, which 
denotes the fact that the quantity is a two-dimensional concentration and has units of 
mol/dm2. Moreover, the antibody is bivalent so that the PLs complex can rearrange on 
the surface and bind to a second hapten to form PL2s: 
sssD LPLPLK ][][][ 22 =                                          (2.6) 
where KD2 is the second dissociation constant. The total concentration of binding sites on 
the membrane surface, [S]s, can be written as:82  
ssss PLPLLS ][][2
1][
2
1][ 2++=                                 (2.7) 
It is assumed that the measured surface fluorescence is proportional to the surface 
protein concentration.82 Therefore, the normalized surface fluorescence can be written in 
terms of a fractional surface coverage: 
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where F([P]) is the measured fluorescence intensity when the bulk concentration of 
labeled antibody is [P]. F([ ∞ ]) is the fluorescence intensity when the membrane surface 
is completely saturated with dye-labeled antibodies. The parameter, α, is a constant that 
varies between 0.5 and 1.0 and reflects the degree of monovalent vs. bivalent antibody 
binding.82 Formally, its value is dependent upon KD2 as: 
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Finally, the value of the overall apparent equilibrium dissociation constant at the surface, 
KD, depends upon both KD1 and KD2: 
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 Representative binding isotherms for anti-biotin and anti-DNP antibodies are 
shown in Figure 4. Measurements were made with phospholipid membranes consisting 
of 5 mol % of the ligand and 95 mol % POPC. It should be noted that the concentration 
of a free antibody in solution, [P], was equal to the applied concentration because the 
protein was continuously flowed through the microfluidic channels until equilibrium was 
established. The value of KD for biotin/anti-biotin was 3.6 (±1.1) nM. By striking 
contrast, DNP/anti-DNP binding was much weaker. In this case KD was 2.0 (±0.2) µM. 
Such a result is remarkable because these binding constants were nearly identical in bulk 
solution (Figure 2.3). At membrane interfaces, however, they differ by three orders of 
magnitude. 
 The KD values obtained in Figure 2.4 should not be directly compared with the 
KD(bulk) values obtained in Figure 2.3. That is because the antibody can bind bivalently 
at the lipid interface and, therefore, the value of KD  is dependent upon both the first and 
second dissociation constants (Eq. 2.10).59,82,90 Nevertheless, it should be pointed out 
that bivalent binding only enhances binding for an IgG by approximately one order of 
magnitude at high ligand density.82 It should be noted that the phosphate groups of 
biotin-cap-PE and DNP-cap-PE were negatively charged (pK~3)91 as well as the 
underlying glass support.92 The antibodies employed in this study were also negatively 
charged at pH = 7.2.  
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Figure 2.4.  Surface binding isotherms. (a) anti-biotin antibody binding to 5 mol % 
biotin-cap-PE and (b) anti-DNP antibody binding to 5 mol % DNP-cap-PE. All data 
points represent the average of three independent runs. The solid lines represent the best 
fit of the data to simple Langmuir adsorption isotherms.  
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The protein charges were experimentally confirmed by pressure-mediated 
capillary electrophoresis,93 which showed that the anti-DNP and anti-biotin antibodies 
bore the same charge. Therefore, electrostatic repulsion effects need to be considered. 
Indeed, Leckband and coworkers have previously reported that substrate electrostatics 
can affect the binding affinity at interfaces.94 However, both the biotin-cap-PE and DNP-
cap-PE supported bilayer systems on glass should bear the identical charge. Therefore, 
electrostatic repulsion probably cannot account for the three order of magnitude 
difference in binding for the DNP/anti-DNP system relative to the biotin/anti-biotin 
system. Indeed, the changes in binding affinity noted by Leckband and coworkers were 
rather modest (less than 1 order of magnitude) for relatively large changes in surface and 
protein charge density. 
Binding at PEG-coated surfaces. SUVs consisting of biotin-cap-PE (1 mol %) 
and varying amounts of PEG5000-PE in POPC were prepared as described in the 
experimental section. Surface binding measurements for the biotin/anti-biotin system 
were performed by the same procedures as described above. The abstracted KD values 
vs. PEG concentration are plotted in Figure 2.5a. Without PEG in the membrane, KD was 
3.6 ± 0.2 nM, but weakened by an order of magnitude with just 0.2 mol % PEG5000-PE. 
Moreover, the equilibrium dissociation constant continued to weaken as the density of 
lipopolymer increased. In fact, the KD value was well into the micromolar range at the 
highest PEG5000-PE concentration (1.5 mol % PEG5000-PE).  The greatest change in the 
KD value occurred between 0.5 and 0.7 mol % lipopolymer. It is well known that PEG-
PE undergoes a structural transition from the mushroom to brush state depending on its  
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Figure 2.5.  Binding between anti-biotin and biotin-cap-PE (1 mol %) at PEG polymer 
(M.W. 5000) coated lipid membrane surfaces. (a) Changes in KD as a function of 
PEG5000-PE concentration. All results are the average of three independent 
measurements. (b) Comparison of the relative fluorescence intensity from bound anti-
biotin at saturation coverage ([IgG] = 20 µM) with varying surface densities of PEG5000-
PE.   
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surface density. Kuhl,95 Bianco-Peled,96 and their coworkers have directly measured the 
polymer thickness changes for this film using neutron reflectivity. PEG5000-PE (M.W. =  
5000 Da) polymers exhibit such transition around 0.5 mol % although it should be noted 
that this transition is rather broad.97 These results appear to indicate that the brush 
conformation is more effective than the mushroom conformation at weakening the 
binding. Such a result is consistent with the notion that polymer molecules need to be 
pushed out of the way laterally in order for the IgG to bind at the lipid membrane 
surface, which was predicted by Szleifer98 and Halperin.99 This is energetically less 
costly in the more compressible mushroom state. 
In addition to weakening the equilibrium dissociation constant, the amount of 
IgG which can be bound at saturation should also be affected by the density of 
lipopolymer in the membrane. To demonstrate this, membranes containing between 0 
and 1.5 mol % PEG5000-PE were challenged with a saturation concentration of anti-biotin 
(20 μM). The data clearly show that only about half as much IgG can be bound in the 
presence of 1.5 mol % PEG5000-PE compared with the lipopolymer-free case (Figure 
2.5b). This result can be understood on steric ground as there is only a finite amount of 
space for proteins to adsorb when PEG5000-PE is also present. 
It should be noted that increasing the PEG-PE concentration slightly increases 
the negative charge at the interface, although the change is very small compared with the 
large charge density on the underlying glass support.92 Therefore, the relative increase in 
electrostatic repulsion between the surface and the negatively charged antibodies again 
needs to be considered. The results of Leckband and coworkers, however, clearly show 
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that that one needs much larger changes in charge density such as those caused by 
modulating pH to cause modest changes in affinity.94 Moreover, Kenworthy and 
coworkers note that steric repulsion dominates over electrostatic effects for bilayers 
containing PEG2000-PE and PEG5000-PE.100 Therefore, we judge the steric effects to be 
dominant in the present case. 
Binding of anti-DNP to DNP presented on a PEG linker. In an effort to 
modulate the surface binding of DNP to anti-DNP, the hapten moieties were conjugated 
to the end of NH2-PEG2000-PE as described in the experimental section. SUVs were 
elaborated with ~1 mol % DNP-PEG2000-PE and varying concentrations of PEG2000-PE. 
The KD value for the DNP-PEG2000-PE/anti-DNP system was obtained by the same 
procedures described above. KD was found to be 21 ± 10 nM for bilayers containing ~1 
mol % DNP-PEG2000-PE and no additional PEG2000-PE (Figure 2.6a). This value is two 
orders of magnitude tighter than for DNP-cap-PE. To verify that this enhancement in KD 
was only due to a change in ligand presentation, a solution binding constant 
measurement for DNP-PEG2000/anti-DNP was made in bulk solution by fluorescence 
quenching.59 The value of KD was found to be 3.5 ± 0.6 nM, which is the same as the 
value obtained in Figure 3b within experimental error. This explicitly shows that the 
PEG linker does not significantly interfere with the equilibrium dissociation constant. 
Additional control experiments were performed to test the effect of the DNP-
PEG2000-PE concentration on the binding affinity. The results showed that increasing the 
concentration of the PEG ligand up to five fold did not show any change in the measured  
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Figure 2.6.  (a) Anti-DNP binding to ~1 mol % DNP-PEG2000-PE in a POPC 
membrane. The solid line represents the best fit to simple Langmuir adsorption 
isotherms. (b) Plot of Log (KD /[nM]) for ~1 mol % DNP-PEG2000-PE with varying 
concentrations of PEG2000-PE. All binding data were fit to simple Langmuir isotherm. 
The data points represent the average of three independent measurements. 
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KD value. Therefore, this system appears to be insensitive to surface ligand density. To 
test the influence of DNP-PEG2000-PE conformation on binding affinity, experiments 
were conducted by adding PEG2000-PE to the membrane (up to 9 mol %), while holding 
the DNP-PEG2000-PE concentration constant (Figure 2.6b). It is well known that 
increasing the polymer density causes these species to adopt a more brush-like 
conformation. 95,96,101,102 Again, no change was found in binding affinity, which indicates 
that the binding is also apparently insensitive to the conformation of the polymer-
conjugated DNP ligand. A final control was performed by repeating these measurements 
using a biotin-PEG2000-PE/anti-biotin system. Again, the KD value was insensitive to 
ligand density and conformation (KD = 3.6 ±1.0 nM). It should be noted that the biotin-
PEG2000-PE/anti-biotin KD value is identical within experimental error to the one for the 
biotin-cap-PE/anti-biotin system.  
 
Discussion and conclusion 
Effect of hapten density vs. ligand presentation. The results in Figure 2.3-2.6 
clearly demonstrate that protein-ligand interactions at lipid membrane interfaces can be 
strongly affected by ligand presentation. By contrast, our laboratory has previously 
reported results for the binding behavior of anti-DNP to DNP-cap-PE in a lipid bilayer 
as a function of ligand density.82 In that case, the apparent equilibrium dissociation 
constant was found to be strengthened by only one order of magnitude as the ligand 
density was increased from 0.1 to 5.0 mol %. Moreover, we have recently investigated 
the pentavalent binding of cholera toxin to ganglioside GM1 as a function of the 
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glycolipid density.34 In that case the binding was actually weakened by slightly less than 
one order of magnitude by increasing the ligand density from 0.02 mol % GM1 to 10 mol 
% GM1. This decrease occurred because ganglioside-ganglioside interactions helped to 
inhibit ligand-protein binding. The present results suggest that ligand presentation is a 
more effective method than changes in ligand density for modulating the thermodynamic 
properties of interfacial binding.  
Lipophilicity. The KD(bulk) values for biotin/anti-biotin and DNP/anti-DNP are 
virtually identical, yet the KD values for the same binding pairs differed dramatically at 
the bilayer interface (Figure 2.3 and 2.4). We postulate that the relative lipophilicity of 
the hapten moieties is the origin of this dramatic difference. In fact, the octanol-water 
partition coefficient (log P) for DNP is 1.5,103 but only 0.11 for biotin.104 DNP is known 
to penetrate the outer membrane of mitochondria and associate with the inner membrane 
105. Balakrishnan and coworkers suggested that DNP haptens as well as other lipophilic 
molecules could bury themselves into lipid membranes via interactions with the aliphatic 
portions of the bilayer.61 Qualitative results from their studies suggested that binding was 
stronger for gel phase membranes than for bilayers in the liquid crystalline phase. By 
contrast, the relatively hydrophilic biotin moiety should largely prefer the aqueous 
phase. In fact, the ureido moiety, (-NH-CO-NH-), of the 2-imidazolidone ring of biotin 
molecules undergoes hydrogen bonding interactions with biotin-binding proteins such as 
avidin and streptavidin.106,107 Therefore, biotin should probably also bind to water in 
aqueous solution and thereby be more available for IgG binding.  
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Screening of anti-biotin by PEG density. PEG-coated lipid membrane surfaces 
can inhibit the binding of anti-biotin to surface conjugated hapten moieties (Fig. 5). Such 
an effect should be related to the types of mechanisms that are normally thought to be 
involved in the repulsive interaction between proteins and PEG films. In fact, the 
inhibition depends on PEG surface density just as is the case with resistance to 
biofouling.108 Namely, increasing the surface density clearly shows a marked effect at 
the onset of the mushroom-to-brush transition. Szleifer98,109 and Halperin99 have 
provided theoretical insights into such steric repulsion mechanisms by modeling 
nonspecific protein adsorption. According to Szleifer, the protein must displace the 
polymer chains laterally in order to sit on the surface. This causes conformational 
entropy losses for the polymer molecules as well as protein-polymer repulsion, but is 
offset by protein-surface attractions.110 Halperin predicted two possible nonspecific 
adsorption mechanisms for proteins on PEG films: an invasive mechanism at the surface 
and a compressive mechanism at the outer edge of the polymer brush. Small proteins 
penetrate the brush conformation with a relatively low free energy penalty (invasive 
mechanism). By contrast, large proteins indirectly contact the surface by compressing 
the polymer brush (compressive mechanism). Both Szleifer and Halperin predicted that 
the inhibition of protein adsorption is more pronounced with increasing PEG density 
rather than just increasing PEG chain length.99,109,111 These theoretical models are in 
good agreement with our experimental results for specific ligand-receptor interactions. 
Effect of a PEG linker on DNP presentation. Our results clearly demonstrate 
that the KD value for the DNP/anti-DNP system can be strongly modulated by ligand 
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presentation using a PEG tether. We found that the KD value for the DNP/anti-DNP 
system in the presence of the PEG tether was enhanced by two orders of magnitude at 
surfaces. These results seem to indicate that the solution properties in the environment 
immediately surrounding the ligand are critical. The use of a long hydrophilic polymer 
tether above the membrane almost certainly increases the partitioning of the DNP into 
the aqueous phase. As noted above, the octanol-water partition coefficient for DNP is 
1.5.103 This implies that DNP should favorably partition into the lipid bilayer compared 
to the adjacent aqueous phase. When a PEG linker is added, the DNP moiety instead 
must partition between the polymer film and the aqueous phase. Since the PEG layer is 
not as a hydrophobic as the lipid interface, a more equal partitioning should be expected. 
In fact, Slzeifer and coworker predicted that PEG polymer spacers increase the 
availability of the ligand, attenuate lateral repulsions, and, thereby, increase binding.75 
It should be noted that the equilibrium dissociation constant for the DNP-
PEG2000-PE/anti-DNP system was still one order of magnitude weaker than for the 
biotin-PEG2000/anti-biotin system at the membrane interface. Leckband and coworkers 
reported that PEG interacts at least modestly well with nonpolar, hydrophobic groups. 
112,113 We, therefore, suggest that the DNP moiety probably still partitions to a significant 
extent into the hydrated PEG region in the present system.   
Finally, it should be emphasized that the nanomolar equilibrium dissociation 
constant with the PEG tether represents the strongest binding for anti-DNP to a 
membrane-associated DNP for any method reported to date. By contrast, the 
introduction of cholesterol to a bilayer was found to only mildly enhance the binding 
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constant.114 The use of a short PEG spacers such as (EO)2 or (EO)4 also had only a very 
modest effect.115  
Glycocalix. The results presented herein lead to a central question. How does 
nature manipulate ligand presentation at a cell surface to regulate ligand-receptor 
binding?  For example, does the cell's glycocalix, which consists of a network of 
glycoproteins, glycolipids, and related sugar moieties, serve to modulate or completely 
screen aqueous proteins based on their size? Moreover, are the equilibrium dissociation 
constants for drug molecules to membrane proteins really significantly altered from bulk 
values by the presence of the glycocalix? It is generally believed that the carbohydrate 
shell on the plasma membrane leads to the stabilization of the structure of the membrane 
via a variety of intra- and intermolecular physical interactions.116 For drug molecules to 
bind target proteins, however, they must also often initially interact with membrane 
phospholipids.117 Some investigations suggest that the composition of the lipid bilayer 
itself can affect drug sensitivity.54,118 The results from the present experiments seem to 
be consistent with the notion that this sensitivity may arise from changes in the 
partitioning of the small molecule between the aqueous and lipid phases based upon 
hydrophobicity. This effect along with steric interactions may be the dominant properties 
attenuating apparent in vivo binding constants compared with those found in aqueous 
solution. 
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CHAPTER IV 
DETECTING PROTEIN-LIGAND BINDING ON 
SUPPORTED BILAYERS BY LOCAL pH MODULATION* 
 
Introduction 
 
Ligand-receptor binding is ubiquitous in the chemical and biological sciences. 
Monitoring such interactions is often performed by fluorescently labeling the proteins or 
nucleotides of interest. In fact, fluorescent tags have become a standard tool for detecting 
biomolecules. Protein labeling can, however, interfere with detection measurements and 
be highly inconvenient to employ.8 This has been a major driving force behind the 
development of assays that can detect biological analytes in a label-free fashion. To date, 
methods include the use of liquid crystalline phase transitions,9,10 colloidal particle phase 
transitions,11 nanoparticles,119-121 semiconductor nanowire conductivity,12-14 quartz 
crystal microbalance (QCM) measurements,15-17 and surface plasmon resonance (SPR) 
spectroscopy18/imaging (SPRI).122-124 Most of these techniques are performed at 
interfaces, but techniques to detect analytes in bulk solution are also being 
developed.125,126  
Despite the tremendous progress in label-free detection, no technique to date 
offers the sensitivity and flexibility of fluorescence-based measurements. Indeed, 
fluorescence measurements can routinely by made down to the single molecule level 
____________    
* Reproduced with permission from “Detecting Protein-Ligand Binding on Supported 
Bilayers by Local pH Modulation” by Jung, H., Robison, A. D., and Cremer, P. S. 2009. 
J. Am. Chem. Soc., 131, 1006-1014 Copyright 2009 by American Chemical Society. 
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without the need for subsequent signal amplification steps. Moreover, fluorescent-based 
devices provide rapid readout and can be easily employed in an array-based format. 
Finally, with the exception of the protein tagging step itself, fluorescence 
spectroscopy/microscopy is relatively easy to perform. These advantages raise the 
question as to whether such techniques could be exploited for interfacial analyte 
detection without the need for tagging the target molecule. Instead, a fluorescent dye 
would be embedded onto the surface of a detection platform and employed as a universal 
sensing element for ligand/receptor binding in much the same way fluorescent dyes can 
be used to sense changes in pH or metal ion concentrations in bulk solution. Surprisingly, 
relatively little work has been performed until now to explore the use of fluorophores as 
an integral part of sensor platforms for detecting biomacromolecule binding. In one 
example, Swanson and co-workers exploited the aggregation of ligand-conjugated dye 
molecules to detect multivalent protein binding via a fluorescence quenching 
mechanism.127,128 Also, Groves and co-workers exploited the change in the diffusion of 
membrane-bound fluorophores to detect protein binding.129  
Herein, we employ pH sensitive fluorescent dye molecules to create biosensors 
that can be employed to monitor multivalent ligand-receptor interactions on supported 
lipid bilayers (SLBs). The dye fluoresces strongly in the protonated state, but becomes 
inactive upon deprotonation. The underlying physical principle for our detection method 
is based upon the idea that the binding of proteins to ligands at a surface will perturb the 
interfacial pH relative to the bulk value. Most proteins are negatively charged at 
physiological pH. Therefore, when these biomacromolecules adsorb on a surface, they 
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recruit hydronium ions with them and thereby lower the interfacial pH. Such local 
acidification is then reported by membrane-bound fluorophores near their titration point. 
A schematic diagram of this concept is shown in Figure 3.1. As can be seen, ligands 
(gray triangles) are incorporated into an SLB along with pH sensitive fluorescent dye 
molecules (shown in pink). The fluorophores are initially inactive. The binding of the 
negatively charged protein causes them to protonate and fluoresce strongly (shown in 
red). Precedence for this interfacial sensing idea is based upon the non-specific 
adsorption of charged polymers to oppositely charged surfaces to change the surface 
potential. For example, the pH sensitive fluorophore, hydroxycoumarin, has been 
employed to monitor the loading of DNA onto cationic liposomes in aqueous 
solution.130,131 Moreover, it has been suggested that this concept might be applicable for 
other types of biomolecules, although no experiments were attempted.132  
Most proteins possess a relatively modest charge per unit mass near 
physiological pH compared with DNA. Therefore, one needs to employ a very stable 
fluorophore as the pH sensitive interfacial detection element. Moreover, a suitable 
control system against which pH changes can be measured is also required. Texas Red 
DHPE is an ideal candidate for such measurements (Figure 3.2). Texas Red DHPE is 
made from Texas Red sulfonyl chloride via addition of the free amine from the head 
group of 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DHPE). Because 
Texas Red sulfonyl chloride consists of an ortho and a para isomer,133 the conjugated 
lipid product is ultimately an isomeric mixture. The ortho-conjugated isomer fluoresces 
when the sulfonamide is protonated, but not when it is deprotonated (Figure 3.2a).134  
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Figure 3.1.  Schematic diagram illustrating the principle of a pH sensitive dye as a 
reporter for interfacial binding of negatively charged proteins. (Before) In the absence of 
proteins, the dye molecules fluoresce relatively weakly. (After) Upon specific protein 
binding, the dye molecules fluoresce strongly. 
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Figure 3.2.  Ortho-and para-conjugated Texas Red DHPE. (a) The ortho and (b) para 
forms of Texas Red sulfonyl chloride are shown at the top. Both isomers can be 
conjugated to a primary amine (DHPE in this case). The ortho isomer forms a five 
membered ring upon deprotonation of the sulfonamide by attacking the xanthylium ring 
system (a). The para isomer does not undergo an equivalent reaction because of  
geometric constraints (b).  
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The process is perfectly reversible and it is possible to toggle back and forth 
between the two states by raising and lowering the pH.133 This isomer is suitable for use 
as a pH sensor. By contrast, the para isomer of Texas Red DHPE is a pH insensitive dye 
and can be employed as a reference for determining relative changes in fluorescence 
intensity of the ortho-conjugated dye (Figure 3.2b). It should be noted that it is 
straightforward to separate the ortho and para isomers via thin layer chromatography 
(TLC) as well as by electrophoretic separation in a bilayer matrix.44 
Herein, we demonstrate the use of ortho-conjugated Texas Red DHPE as a 
reporter of local pH modulation in supported lipid bilayers. The apparent pKA of this 
molecule in an SLB containing 0.5 mol % biotin-cap-PE on glass was found to be 7.8 ± 
0.1. The dye molecule could be used to generate a binding curve for the biotin/anti-
biotin pair at the SLB interface. The equilibrium dissociation constant, KD, was found to 
be 24 ± 5 nM. This value is in good agreement with measurements made by total internal 
reflection fluorescence microscopy (TIRFM) using dye-labeled proteins. Moreover, the 
limit of detection (LOD) for the antibody was ~350 fM at the 99 % confidence level. 
This is about 69,000 times smaller than the corresponding KD value. In imaging mode, 
the assay could detect fewer than 400 IgG molecules in a single 4 × 4 binned pixel 
region. Thus, this assay compares extremely favorably with previously developed 
detection techniques.  
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Results 
Titration curves for ortho-Texas Red DHPE. In a first set of experiments, the 
pH dependent responses of the ortho- and para-conjugated Texas Red dyes were 
investigated in supported POPC bilayers with 0.5 mol % biotin-cap-PE. Titration 
experiments were systematically performed by changing the pH of the bulk solution 
stepwise from pH 10.2 to 4.0. Bulk solutions at a given pH value were continuously 
flowed into the device until the fluorescence intensity remained constant. Fluorescence 
images at each pH value were then captured (Figure 3.3a). As can be seen, the intensity 
of the para band remained nearly unchanged, while the ortho band showed higher 
intensity at more acidic pH values. No evidence for hysteresis was observed by returning 
the pH back to 10.2 from 4.0 or even by cycling the pH several times. The normalized 
peak area of the ortho band relative to the para band as a function of pH is plotted in 
Figure 3.3b and an apparent pKA value of 7.8 ± 0.1 can be abstracted from the data.  
Next, we attempted to determine how fast ortho-Texas Red DHPE can respond to 
bulk pH changes. To do this, two separated bilayer strips were formed containing the 
ortho and para dyes, respectively. Time-sequence fluorescence images were obtained as 
the bulk pH was abruptly increased from 4.0 to 10.2. The fluorescence micrographs and 
line profiles as a function of time are shown in Figure 3.4. As can be seen, the 
fluorescence changed almost as abruptly as the pH could be raised (i.e. within a few 
seconds). Such a result is in agreement with the response of an ortho-conjugated 
sulforhodamine isomer in bulk aqueous solution, which can respond to pH changes on  
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Figure 3.3. Titration curve for ortho-Texas Red DHPE. (a) Fluorescence images of 
supported POPC bilayers containing para and ortho-conjugated Texas Red DHPE in two 
adjacent bands. Each bilayer strip contained 0.5 mol % biotin-cap-PE and ~0.03 mol % 
of the respective fluorescent dye. The images were taken from pH 10.2 to pH 4.0. A 4× 
air objective was used to make these measurements. An example of the region from 
which intensity line profile data was abstracted is denoted with a red line in the first 
image. (b) Relative intensity for the ortho-conjugated isomer of Texas Red DHPE as a 
function of pH. The black circles represent individual fluorescence measurements and 
the solid line is a sigmoidal fit to the data. Error bars representing standard deviation 
measurements from three data sets are denoted on each data point. To obtain the y-axis, 
the intensity of the ortho band was divided by the intensity of the para band at each pH 
value. This ratio was normalized to 1.0 at pH 4.0. All intensity ratios are relative to this 
normalization. 
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Figure 3.4.  The time response of ortho and para-conjugated Texas Red DHPE bands 
in a supported bilayer to an abrupt jump in pH from 4.0 to 10.2. (a) pH originally set to 
4.0, (b) buffer solution at pH 10.2 is flowed over the surface, (c) 2 s later, and (d) 3 s 
later. Both an epifluorescence image and a corresponding line profile are shown for each 
time period. An example of the region across which the line profile was taken is denoted 
with a red line in (a). A 4× air objective was used to make these measurements.  
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the millisecond time scale.133 Moreover, it appears that Texas Red DHPE molecules in 
both leaflets of the bilayer are rapidly able to sense the pH jump. 
Titration curve with a saturated protein layer. The ortho-Texas Red DHPE 
isomer should be an excellent reporter for small changes in the local pH brought about 
by the binding of proteins from bulk solution. To demonstrate this principle, the 
biotin/anti-biotin antibody binding pair was employed as a test system. First, two 
separated bilayer strips were formed as described above. Then, the surface was saturated 
with anti-biotin IgG by the introduction of a 500 nM protein solution over the surface for 
10 minutes. All subsequent measurements were made by tuning the solution pH value, 
but keeping the bulk IgG concentration constant.135 The results shown in Figure 3.5 
reveal an apparent shift of ~0.35 pH units with respect to the results in Figure 3.3,136 
which were taken in the absence of bound proteins.  
Binding curve for anti-biotin antibodies. To obtain the equilibrium 
dissociation constant for the biotin/anti-biotin system, POPC bilayers containing 0.5 mol 
% biotin-cap-PE and ~0.03 mol % ortho-Texas Red DHPE were coated on the inside 
walls and floors of a seven channel PDMS/glass microfluidic device. Experiments were 
run in all channels at a bulk pH of 8.2. Concentrations of antibodies ranging from 0 to 
200 nM were flowed continuously through the individual channels until the fluorescence 
intensity from the surface-bound dyes remained constant. Epifluorescence images from  
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Figure 3.5.  Titration curve with a saturated protein layer. (a) Epifluorescence images 
of para-Texas Red DHPE (upper) and ortho-Texas Red DHPE (lower) strips at different 
bulk solution pH values in the presence of a saturation concentration of anti-biotin. (b) 
Relative intensity ratio for ortho-Texas Red DHPE as a function of pH. The black circles 
represent fluorescence measurements and the solid line is a sigmoidal fit to the data (R2 
= 0.99). To obtain the y-axis, the intensity of the ortho band was divided by that of the 
para band at each pH value and the value at pH 4.0 was set to 1.0. All other intensity 
ratios are relative to this value. Error bars representing standard deviation measurements 
from three data sets are denoted on each data point. A 10× air objective was used to 
make these measurements. The red line across the first image in (a) denotes an example 
of the region from which intensity line profile data were abstracted.  
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the device used in these experiments are shown in Figure 3.6a. As can be seen, weaker 
and uniform fluorescence intensity was observed in all channels before the addition of 
protein. After the IgG molecules were introduced, however, the fluorescence intensity 
was strengthened in accordance with the bulk concentration of the antibodies.  
Line profiles taken from the images (blue and red lines in Figure 3.6a) are plotted 
in Figure 3.6b. As can be seen, the fluorescence intensity after the introduction of the 
protein molecules increased and then leveled-off as the protein concentration was 
increased. It should be noted that the fluorescence intensity from the ortho-Texas Red 
DHPE was enhanced after protein binding by 1.4 times at the highest two bulk protein 
concentrations. Based on the curve in Figure 3.3b, the initial fluorescence intensity was 
42 % of the maximum value and ended at 60 % of the maximum value upon protein 
binding. It should be noted that this interfacial pH shift occurred in the regime where the 
fluorescence intensity varied nearly linearly with pH (Figure 3.3b).  
The normalized increase in fluorescence intensity as a function of bulk antibody 
concentration from Figure 3.6b is plotted as a function of bulk protein concentration in 
Figure 3.6c. Specifically, the y-axis plots the change in fluorescence intensity (ΔF) 
relative to the maximum change in fluorescence intensity when a saturation 
concentration of protein is present (ΔFmax). In order to extract the apparent equilibrium 
dissociation constant (KD), the biotin/anti-biotin binding curves were fit to a simple 
Langmuir isotherm binding model (eq 1):  
][
][
max PK
PFF
D +
×Δ=Δ                                                                (3.1) 
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Figure 3.6.  pH sensor-based binding assays. (a) Epifluorescence images of a bilayer 
coated microfluidic device before and after the introduction of unlabeled anti-biotin 
antibodies. The concentration of protein in the bulk solution was increased from left to 
right. The blue and red lines represent the regions used to obtain the line profiles shown 
in (b). (c) A plot of normalized fluorescence intensity (ΔF/ΔFmax) vs. bulk protein 
concentration. The solid line represents the best fit to a Langmuir isotherm. (d) 
Experimental line profiles for the same conditions shown in (b), but with para-Texas 
Red DHPE in the membrane instead of ortho. (e) Experimental line profiles for the same 
conditions shown in (b), but with anti-DNP antibodies. (f) Experimental line profiles for 
the same conditions as in (b), but in the absence of biotin-cap-PE. A 4× air objective was 
used to make all measurements. It should be noted that each data point in (c) represents 
the average of three measurements and the error bars are standard deviations from those 
measurements.
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where [P] is the bulk antibody concentration. The fit to the curve for the data in Figure 
3.6c yields KD = 24 ± 5 nM. 
The biotin/anti-biotin binding experiments were repeated under a nearly identical 
set of conditions, but using para-Texas Red DHPE instead of ortho. The fluorescence 
line profiles both before and after antibody binding are shown in Figure 3.6d. As can be 
seen, little if any change in fluorescence intensity occurred under these conditions. 
Several additional control experiments were also performed. For example, anti-DNP 
antibodies, which are not specific for biotin, were used instead of the anti-biotin 
antibodies. Also, experiments were performed with anti-biotin antibodies and ortho-
Texas Red DHPE, but without any biotin-cap-PE in the membrane. In both of these 
cases, the fluorescence intensities from the microchannels remained unchanged within 
experimental error upon the introduction of protein (Figure 3.6e & 3.6f, respectively). 
Such results are consistent with both high ligand-receptor specificity as well as relatively 
low levels of non-specific protein adsorption to the surface. 
Next, classical antibody binding experiments were performed using anti-biotin 
antibodies labeled with Alexa Fluor-594 dye (Figure 3.7). Binding measurements were 
made by total internal reflection fluorescence microscopy (TIRFM)137 as described 
previously.36 In this case the supported membranes contained 99.5 mol % POPC and 0.5 
mol % biotin-cap-PE. These experiments yielded a KD value of 32 ± 7 nM. Therefore, 
the classical label and pH modulation assays gave nearly identical results within 
experimental error. Moreover, both values correlated well with previously reported 
values for biotin/anti-biotin interactions on supported membranes.138  
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Figure 3.7.  Plot of TIRFM intensity vs. bulk protein concentration for the labeled anti-
biotin/biotin binding system. Each data point represents the average of three 
measurements and the error bars are standard deviations from those measurements. The 
solid curve through the data is the best fit to a Langmuir isotherm. 
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The similarities between the classical and pH modulation measurements as well 
as the associated control experiments are strong evidence for the reliability of the new 
assay. Specifically, the change of fluorescence intensity in the pH modulation assay 
appears to correlate linearly with the interfacial antibody concentration under the 
conditions of these measurements. Moreover, it should be noted that this assay is far 
easier to perform than its protein labeled counterpart. In fact, the classical binding assay 
requires that the antibodies be conjugated with fluorescent dye molecules and that free 
dye be subsequently separated from the labeled antibodies by running the mixture down 
a size exclusion column. Once the labeled antibodies are introduced into the 
microchannels, the fluorescence assay must discriminate between antibodies bound to 
the surface and those in the bulk solution above it. As noted above, this was done in the 
present case by TIRFM, a surface specific technique that requires a laser beam to be 
introduced to the sample past the angle of total internal refection.139 By contrast, the pH 
modulation assay can be run in standard epifluorescence mode because the pH sensitive  
dye molecules are already located at the interface within the supported bilayer. Of 
course, no modification of the antibodies is needed to do these experiments. 
Limit of detection (LOD) measurements. In a final set of experiments, we 
wished to determine the LOD value for this pH sensor assay by two different metrics. 
First, the CCD camera was used in imaging mode to determine the fewest number of 
IgG molecules that could be sensed. In that case 4 × 4 pixel binning was employed, 
which corresponds to a 1.7 µm2 area at the lipid bilayer interface. Second, the 
experiments were repeated with 200 × 200 pixel binning to determine the lowest number 
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density of IgG molecules where could be detected. The camera contains a 1024 × 1024 
pixel array. 
To perform 4 × 4 binning experiments, supported bilayers were made from 
POPC lipids doped with 0.5 mol% biotin-cap-PE and ~0.03 mol% ortho-Texas Red 
DHPE. Concentrations of anti-biotin IgG ranging from 0 to 100 pM were introduced into 
the bulk solution. Line profiles both before and after the introduction of the protein are 
shown in Figure 3.8. As can be seen, the fluorescence intensity remained essentially 
unchanged when 0 pM anti-biotin was added (pure PBS buffer flowed for 60 min), but 
changed by ~8 % when 100 pM anti-biotin was added. It should be noted, that intensity 
changes were linear with concentration between 0 and 100 pM antibody as shown in 
Figure 3.8f (red circles). The slope of the line and its corresponding R2 value is provided 
as an inset in the figure.  
Error analysis of the intensity profiles revealed that the averaged fluorescence 
intensity over a given channel was stable to within ± 0.2 % over a 1 h time period. This 
gives an LOD value of ~8 pM if the limit of detection is defined as 2.58 times the 
experimental error. It should be noted that this definition of LOD was chosen because it 
represents the 99 % confidence limit for these measurements.140 Control experiments 
with para-Texas Red DHPE under the same conditions showed that little if any change 
in fluorescence intensity occurred when the antibody was introduced (Figure 3.8f, black 
circles). Additional control experiments were performed with anti-DNP as well as 
without any biotin-cap-PE in the membrane (data not shown). No observable change in 
fluorescence intensity occurred.  
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Figure 3.8.  LOD results for 4 × 4 pixel binning. (a)-(e) Intensity line profiles across 
single microfluidic channels as various concentrations of anti-biotin antibodies were 
introduced to the bulk solution. The experiments were conducted at a bulk pH of 7.8 in 
10 mM PBS with 150 mM NaCl. (f) A plot of the change in the fluorescence intensity of 
the ortho-Texas Red DHPE, ΔF(%), vs. bulk protein concentration (red circles). A 
control experiment was also performed with para-Texas Red DHPE in the membrane 
under otherwise identical conditions (black circles).  
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Next, the LOD was determined using 200 × 200 pixel binning. This dimension, 
which represents a 65 µm × 65 µm region of the liquid/solid interface, was chosen 
because it corresponds well to the width of an individual microfluidic channel. The 
experimental conditions were identical to those used above except for that pH was 8.2 
for this experiments. Concentrations of anti-biotin ranging from 0 to 1.5 pM were 
introduced into the bulk solution. In this case, single data point intensities were recorded 
as a function of time (Figure 3.9a to 3.9e). Approximately 50 data points were obtained 
for each sample region over the course of 400 sec both before and after the introduction 
of protein. This was done to improve the signal-to-noise of the experiment. As can be 
seen, the fluorescence intensity remained stable to within ± 0.3 %. The data at each 
antibody concentration were averaged and plotted in Figure 3.9f (red circles). The LOD 
value was found to be ~350 fM at the 99 % confidence limit.  
 
Discussion and conclusion 
We have developed a novel pH sensitive assay for monitoring ligand/receptor 
binding at lipid membrane interfaces. The method should be quite general since most 
biomacromolecules in solution bear a net charge. Specifically, we found a shift of ~0.35 
pH units occurred upon saturation binding of IgG to a lipid membrane with 0.5 mol% 
lipid-conjugated haptens compared to the case of no bound proteins. Such a result is in
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Figure 3.9.  LOD results for 200 × 200 binned pixel regions. (a)-(e) Single point 
fluorescent intensity measurements as a function of time both before and after the 
introduction of various concentrations of anti-biotin. (f) A plot of fluorescence intensity 
for ortho-Texas Red DHPE, ΔF(%), vs. bulk protein concentration (red circles). The 
slope of the line and its corresponding R2 value are provided in the figure.  
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agreement with the notion that increasing the density of negative charge at the interface 
recruits counterions (especially hydronium ions). In fact, Fromherz has suggested that 
changes in membrane potential can affect the interfacial concentration of hydronium 
ions and thereby shift the local pH.141 Also, Latour and co-workers demonstrated that 
deprotonated COOH-terminated self-assembled monolayers (SAMs) attract hydronium 
ions to the interface, thus resulting in a decrease of the local pH value.142 Changes in 
interfacial charge density, therefore, should lead to corresponding shifts in the apparent 
pKA values of titratable surface groups relative to their values in bulk solution.131 This 
makes the titration of fluorescent dye molecules useful for sensor development. How 
useful this phenomenon can be for assay development ultimately depends upon its 
sensitivity. 
Sensitivity limits for biosensor platforms are often reported in the literature in 
terms of the minimum bulk analyte concentration that can be detected.143 However, the 
LOD is usually strongly correlated to the strength of a given ligand/receptor binding 
event. For example, a typical antibody/antigen interaction might have a KD value of 25 
nM, while a tighter protein/ligand interaction could be KD = ~1 pM. A heterogeneous 
detection assay (i.e. detection of the analyte by binding to a surface from solution) might 
have a detection limit of 250 pM for the former, but 10 fM for the latter. In reality, these 
apparently different bulk detection limit values may actually represent similar number 
densities of proteins at the interface because each LOD value would be 1 % of KD. 
Therefore, the number of proteins at the interface which can be detected may represent a 
more intrinsic measure of the LOD value for a particular assay platform. 
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In the studies described in Figure 8, we employed 0.5 mol % biotin-cap-PE and 
used 4 × 4 pixel binning of our CCD camera with a 40× oil immersion objective for 
detection. This corresponds to a 1.7 μm2 surface area at the liquid/solid interface for each 
binned pixel region. The area per lipid molecule in the membrane is known to be ~0.7 
nm2/lipid.144 By assuming that biotin-cap-PE is roughly the same size as the lipids, 0.5 
mol% of this molecule translates to ~7 × 103 ligands/μm2 on the upper bilayer leaflet. 
The intensity change at 500 nM IgG is ~150 times greater than that observed at the LOD 
(~8 pM). Therefore, the number density of proteins at the interface should be ~150 times 
less than the saturated value. This results in a detection limit of ~380 IgG molecules if 
one assumes a 2:1 binding ratio between the antibody and the antigen.139 Such a non-
optimized result is within a few orders of magnitude of single molecule measurements. 
This result corresponds to a surface density of 56 pg/mm2. This surface density LOD 
value can be substantially improved by binning together a larger number of pixels while 
making the binding measurements. Although one loses the ability to obtain a surface 
image, the signal to noise ratio should roughly improve with the square root of pixels 
employed. Additional improvements can be obtained by time averaging. The data for 
200 × 200 pixel binning are provided in Figure 3.9. Such data represents an antibody 
surface density of ~2 pg/mm2. Moreover, the 350 fM LOD is a factor of ~69,000 lower 
than the KD value of 24 nM, although one is no longer sensing just a few hundred IgG 
molecules. It should be possible to sense even lower number densities of proteins by 
binning an even larger number of pixels together. Indeed, simultaneous sensing over a 1 
mm2 area should reduce the number density detection limit by yet another order of 
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magnitude. In that case, however, the ability to perform multiplex detection is 
completely eliminated.  
Currently, surface plasmon resonance (SPR) is one of the most commonly 
employed label-free assays for monitoring ligand/protein binding at an interface. Direct 
comparisons between assays can sometimes be problematic. Therefore, we will limit this 
discussion to antibody/antigen binding measurements. In that case, SPR platforms in a 
Kretschmann configuration145 gave rise to an LOD of ~3 pM for a system with a KD 
value of ~4 nM.18 For the present assay, we achieved a detection limit significantly 
better than that (~350 fM out of 24 nM). Of course, the sensitivity limits for SPR and 
SPRI can be vastly improved by secondary amplification steps.120,146,147 By analogy, 
LOD from the current pH modulation assay could also be substantially enhanced by 
subsequent amplification procedures after antibody binding.  
It should be noted that the pH modulation platform developed here should be 
highly versatile. Binding measurements were made on two dimensionally fluid lipid 
bilayers because these systems are laterally mobile and should allow the same type of 
multivalent protein binding to take place as occurs in vivo on a cell surface.24 Moreover, 
supported lipid bilayer platforms are highly resistant to non-specific protein 
adsorption.148 Nevertheless, this sensing concept could be expanded to any liquid/solid 
interface that contains substrate-conjugated ligands and pH sensitive fluorophores. It 
should also be capable of measuring nearly any protein-ligand binding event provided 
that the incoming macromolecule possesses a net charge and therefore changes the 
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interfacial pH. As another demonstration of the universality of this method, the binding 
of cholera toxin B to ganglioside GM1 is provided in Figure 3.10. 
In conclusion, a simple detection method based on pH sensitive dyes was 
developed. Specifically, ortho-conjugated Texas Red DHPE incorporated in supported 
phospholipids bilayers was used as an interfacial pH sensor. Such sensors have 
inherently excellent limits of detection and are relatively easy to use. Moreover, the 
method is fully compatible with multiplexed detection. Therefore, it could potentially be 
used in high throughput screening applications.  
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Figure 3.10.  Binding constant measurements for cholera toxin B to GM1 in 
POPC/ortho-Texas Red DHPE membranes. The experimental conditions were identical 
to those for the biotin/anti-biotin binding pair, but contained 0.5 mol % GM1 instead of 
biotin-cap-PE. Moreover, the measurements were made at a bulk pH value of 8.2 (a) 
Epifluorescence images of the seven channel device before and after the introduction of 
the toxin. (b) Fluorescence line profiles from (a). (c) Fluorescence changes vs. bulk 
protein concentration. The binding curve was fit to a simple Langmuir isotherm as 
shown in Eq. 1 of the main text. The abstracted dissociation constant was KD = 0.45 nM. 
This value is in excellent agreement with literature data obtained by fluorescently 
tagging cholera toxin B.34 
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CHAPTER V 
BILAYER ELECTROPHORESIS USING LIPID RAFTS 
 
Introduction 
 
Separation and purification of membrane components such as lipids and 
transmembrane proteins is a challenging task. Conventional purification methods include 
extraction with detergents, centrifugation at high speeds, column chromatography and 
gel electrophoresis. These processing conditions can often deteriorate native structures 
of lipids and proteins and result in unwanted loss of materials.  
Recently, our laboratory and other groups demonstrated a new electrophoresis 
method using solid supported lipid bilayers as a separation media for membrane-
anchored components or bilayer electrophoresis.149,150 Solid supported lipid bilayers are 
known to conserve many of the properties of native cell membranes including two 
dimensional fluidity.24 It is generally believed that a thin water layer (approximately 0.5-
1.5 nm in thickness) residing between the lower leaflet of the bilayer and the underlying 
solid support allows lipid bilayers to facilely move within the plane of the surface.24 
Bilayer electrophoresis is an attractive alternative to gel electrophoresis because it is run 
in native-like environments without further exposing the analytes of interest to harsh 
chemicals. A variety of solid supports can be used, from silica surfaces including mica, 
quartz, and glass to chemically functionalized surfaces such as gold, titanium oxide, and 
PDMS.151 So far, several membrane components have been electrophoretically 
manipulated in solid supported lipid bilayers: charged lipids,152,153 tethered vesicles,154 
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and glycosylphosphatidylinisotol (GPI)-linked proteins.155 Recently, Boxer and 
coworkers reported the use of polymer-supported membranes to electrically manipulate 
recombinant proteins.156 Electro-separation of membrane components using lipid 
environments provides an additional advantage: the separation can be simply tuned by 
modulating the lipid chemistry. For example, the presence of cholesterol in the bilayers 
reduced band broadening and improved band resolution during the separation process 
compared with the case in the absence of cholesterol.149  
Rafts, domains enriched in sphingomyelin, saturated lipids, and cholesterol in 
cell membranes,157,158 have attracted interest as they are thought to be involved in many 
important biological functions such as cell signaling,159 protein sorting,12,13 and 
membrane trafficking.160 Their physical state is considered to be a liquid-ordered phase, 
while is distinct from the non-rafts are in a liquid-disordered phase. The partition 
equilibrium of membrane components between rafts and non-rafts is of particular 
interest.  Lipid-anchored proteins are thought to be sorted using the partitioning 
properties of their anchor.160 Indeed, a number of proteins in plasma membranes are 
modified with one or more lipid groups directly linked to the polypeptide backbone, 
suggesting that the lipid-modified sequences may influence the partitioning of proteins 
into rafts or related structures such as caveolae.161 For instance, GPI- or saturated lipid-
anchored proteins preferentially partition into rafts. In contrast, proteins anchored by 
unsaturated lipids are excluded from the raft regions161, although this equilibrium is 
difficult to quantify in real biological systems due to the complexity of such systems.  
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 Rafts have been previously formed using equal molar ratios of 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC), and cholesterol in model membranes. The phase diagram for this particular 
ternary mixture has been described in giant unilamellar vesicles (GUVs) studies.162 
However, unlike GUVs, formation of rafts on solid supported lipid bilayers is reportedly 
sensitive to solid surface treatments and the thermal history of the bilayers.151,163,164 For 
instance, Hovis and coworker formed circular rafts of micrometer size by treating the 
glass substrates with piranha.151   
Here we demonstrate electrophoresis of membrane-anchored components by 
using rafts-containing lipid bilayers on solid support as a matrix. The size of rafts was 
varied from the micrometer to the nanometer range by employing different surface 
treatments including Hovis and coworker’s method. Large micrometer size rafts (large 
microrafts) could be obtained with HF-etched glass substrates where bilayers were then 
heated and slowly cooled down to room temperature. Small micrometer size rafts (small 
microrafts) were formed using methods developed by Hovis and coworkers.151 
Nanometer size rafts (nanorafts) were formed by controlling thermal history of bilayers 
on non-treated glass substrates. Raft and non-raft regions on solid supported lipid 
bilayers were characterized by fluorescence microscopy and nanorafts were further 
investigated using atomic force microscopy (AFM).165,166 These solid supported lipid 
bilayers containing rafts of various size were then used as a matrix to electrophoretically 
separate membrane-anchored lipid mixtures. The two lipid components employed, 
biotin-DPPE and biotin-DOPE, contain the same head group, but differ in the structure  
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Figure 4.1.  Structures: (a) biotin-DPPE and (b) biotin-DOPE. 
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of their lipid anchors, as shown in Figure 4.1. Biotin-DPPE has a doubly-saturated lipid 
anchor (DPPE) and biotin-DOPE has a doubly-unsaturated lipid anchor (DOPE). These 
lipids are expected to have different partitioning preferences in the presence of raft and 
non-raft regions in membranes as illustrated in Figure 4.2. This difference in partitioning 
of the two lipid anchors is then expected to affect the electro-separations. Thus, the 
results show that two clear bands were observed in nanorafts-containing lipid bilayers. In 
contrast, only one band was obtained in microrafts and no rafts-containing bilayers. 
Moreover, it was found that the electrophoretic mobilities (μi) of the two components 
differed in the presence of nanorafts, and the partition coefficient (Kp) of biotin-DPPE 
found to be about 1.6 times higher than that of biotin-DOPE. These results indicate that 
lipid rafts of varying size can be used to both tune and improve the resolution of the 
separation of membrane components using bilayer electrophoresis.  
 
Results and discussion 
Formation of supported lipid bilayers containing rafts of varying size. The 
representative images of supported lipid bilayers containing rafts of varying size are 
shown in Figure 4.3. DOPC, DPPC, and cholesterol were selected to form rafts, and all 
the samples were prepared with equal molar ratios of DOPC, DPPC, and cholesterol. 
Rafts were then formed as described in experimental section. A fluorescent probe, Texas 
Red DHPE was added to the ternary lipid mixtures to visualize the raft and non-raft 
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Figure 4.2.  Partitioning of a membrane-anchored component between rafts and non-
rafts in lipid membranes. 
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Figure 4.3.  Fluorescence images of supported bilayers containing rafts with varying 
size. (a) Large microrafts (11 μm), (b) medium microrafts (7 μm), (c) small microrafts (2 
μm), (d) nanorafts (98 nm), (e) nanorafts (42 nm), and (f) no observable lipid rafts. Rafts 
(dark) and non-rafts (bright) were visualized by Texas Red DHPE. The size of rafts for 
(d)-(f) was further characterized by AFM studies (see Figure 4). The objective used is 
indicated at the bottom from each micrograph. 
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regions in an amount of 0.03 mol %. Microraft formation involved fusing vesicles to 
HF-etched (5 or 10 minutes) glass substrates. It is known that the bilayers need to be 
heated above their phase transition temperature (Tm) to induce phase separation.167 The 
ternary mixtures of equal molar ratios of DOPC/DPPC/cholesterol have Tm values 
around ~29 °C.162 The supported bilayers formed on HF-etched glass were thus 
incubated in a hot water bath (50 °C) for 2 h and slowly cooled down to room 
temperature for 30 minutes. Large, circular micrometer size rafts were formed by this 
procedure: 11 μm with HF-etched (10 minutes) glass and 7 μm with HF-etched (5 
minutes) glass, respectively (Figure 4.3a & 4.3b). The raft regions appear dark in the 
images due to the preferential partitioning of the Texas Red DHPE into the non-raft 
regions.168 The averaged size of rafts was obtained by the estimated diameter of the dark 
regions in epifluorescence images at each condition. Histograms for the apparent size 
distribution of rafts in different experimental conditions are provided in Figure 4.5a & 
4.5b. Fluorescence recovery after photobleaching (FRAP)169 confirmed that the rafts are 
fluid, liquid-ordered phases. In some cases, rafts were observed to be connected, 
indicating that they tend to move and coalesce. This phenomenon was frequently 
observed in GUVs but is rare in supported bilayers.168 It should be further noted that 
roughening of surfaces was not observed by HF etching, as judged by AFM 
measurements (see Experimental Section). When the same vesicles were fused to the 
piranha-etched substrate and then incubated in hot water bath for 1 h, approximately 2 
μm size rafts (Figure 3c) were formed as reported by Hovis and coworkers.151  
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As pointed out in the paper, rafts were not always formed by this procedure 
(reproducibility: < ~ 60 %).  Apparent size distribution of the rafts formed in this 
procedure is also provided in Figure 4.5c. 
To form nanorafts, bilayers formed on baked glass substrates were incubated in 
hot water bath for 1 h and 25 minutes, respectively and then cooled back down to room 
temperature. This procedure resulted in homogeneous images down to the optical 
diffraction limit under what could be resolved using fluorescence microscopy with a 40× 
air objective (Figure 4.3d and Figure 4.3e). Therefore, in order to confirm the formation 
of nanorafts, AFM measurements were performed for those bilayers (see Experimental 
Section for detail). The results revealed that nanorafts of different size were formed 
depending on the heating time (Figure 4.4a & 4.4b): 98 nm-rafts were formed for 1 h 
heating and 42 nm-rafts for 25 minutes heating, respectively. The average size of rafts 
was determined from 1×1 μm2 AFM images. Histograms for the size distribution of 
nanorafts are provided in Figure 4.5d & 4.5e. Interestingly, these rafts are more 
connected and more irregular in shape as compared to the microrafts (Figure 4.3a-c).  
They have ~ 0.7-1.1 nm high features which compare well with the value previously 
reported for supported bilayers consisting of DOPC/DPPC/cholesterol.48 In fact, the 
height difference in the bilayer thicknesses of gel-phase DPPC and fluid-phase DOPC 
was experimentally estimated ~ 1.1-1.2 nm.166,170 In addition, cholesterol is known to 
increase the length of the fluid PC molecule so that the average height difference 
between the rafts and surrounding non-rafts becomes slightly lower than for gel-fluid 
phases.171-173 
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Figure 4.4.  AFM images (1 μm × 1 μm) of supported lipid bilayers containing 
nanorafts. (a) 98 nm (1 h at 50 °C), (b) 42 nm (25 minutes at 50 °C), and (c) no 
observable rafts (no heat treatment).  
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Table 5.1.  Comparison of band resolution (Rs) 
Raft size (a)Snr/Sr (b)Rs 
(expected) 
Rs 
(obtained) 
0 nm 0 0 0 
42 nm (c) ~ 0.8 1.5 1.5 
98 nm (c) ~ 0.6 0.7 1.0 
2 μm ~ 1 0 0.6 
7 μm ~ 3 0 0 
11 μm ~ 5 0 0 
 
(a) Snr = surface areas of non-rafts and Sr = surface areas of rafts  
(b) calculated from Purnell equation174 as follows: 
    
2
211
4 k
kNRs
+−∝ α
α  
where N is the average number of theoretical plates, α is the selectivity factor (Kp1 /Kp2) 
and k2 is the retention factor for component 2 (biotin-DOPE in this case), equal to Kp2β 
where Kp2 is the partition coefficient and β is the phase ratio (equal to Snr/Sr in this case). 
We assumed that N is simply inversely proportional to the square root of particle size175 
and the value of α is independent upon the size of rafts. 
(c) see the texts  
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This is consistent with the results that rafts formed in these experiments are liquid 
ordered phases and not defects or gel phases. Based on the height difference between the 
phases, the elevated phase is assumed to be DPPC- and cholesterol-enriched raft regions 
and the lower phase to be a DOPC-enriched, non-raft region.48,176 Bilayers which were 
formed on baked substrates and not heated looked relatively flat and featureless (Figure 
4.3e & 4.4c). Indeed, no observable rafts were found according to AFM analysis. This is 
consistent with previously reported ideas that the thermal history is necessary to induce 
phase separation in lipid bilayers.167  
Interestingly, changes in the treatment of the solid support not only change the 
size of rafts, but the surface area that they cover in the bilayers. Thus, an attempt to 
estimate the ratio of surface areas between nonrafts and rafts in the bilayers (Snr/Sr) was 
made. The values for microrafts could be easily estimated by assuming that all rafts are 
circular (dark areas in Figure 4.3a-c). The area rafts cover in nanorafts-containing 
bilayers is difficult to determine accurately due to the irregular shape and small size, but 
could be roughly estimated using a particle analysis function provided by nanoscope IIIa 
software (V. 5.30). These results are summarized in Table 5.1 and it is clearly shown 
that nanorafts form more densely than microrafts. However, it should be noted that the 
ratio of surface areas was not controlled in our experimental conditions.  
The representative images shown in Figure 4.3 & 4.4 could be different from the 
matrix lipid bilayers employed in bilayer electrophoresis experiments (see below). It 
should be, however, noted that they are at least similar because rafts were formed from 
batch to batch with high reproducibility.  
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Figure 4.5.  Histograms for the distribution of raft size in supported lipid bilayers. (a) 
nanorafts (42 nm), (b) nanorafts (98 nm), (c) small microrafts (2 μm), (d) medium 
microrafts (7 μm), and (e) large microrafts (11 μm). The standard deviation of the raft 
size was obtained by fitting to a Gaussian function. Each averaged raft size as well as 
standard deviation and total counts for rafts were shown in each panel. 
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 Electrophoresis of two biotin lipids on rafts of varying size in supported 
lipid bilayers. The size of rafts was systematically manipulated from micrometer to 
nanometer as shown in Figure 4.3 and Figure 4.4. Two structurally similar membrane-
anchored components, biotin-DPPE and biotin-DOPE were chosen as analytes (see 
Figure 4.1 for structures) to demonstrate the use of lipid rafts in electrophoresis. The 
experiment was performed with a 2 cm separation length controlled by a PDMS frame 
for 30 minutes, using a field strength of 125V/cm. The electric field lines were setup to 
run parallel to the bilayers and solid support and the positive and negative electrodes 
were located on the right and left sides of the PDMS frame, respectively. When the 
electric field is applied parallel to the bilayer, charged species move by either 
electrophoretic forces or electro-osmosis.154 In these experiments, the phosphate group 
(PE) of biotin lipids (pKa ~ 3)177 is negatively charged (-1) and biotin itself is neutral. In 
cases where the mobile charged component is well within the electrical double layer, 
electro-osmosis is negligible. The Debeye screening length in our experiments is 
typically 1~2 nm, and the biotin molecules linked to the head group of lipids via a linker 
which is approximately 1.2 nm long,178 are well within the double layer. Therefore, 
biotinylated lipids are expected to move by electrophoretic forces toward the positive 
electrode. It should be further noted that rafts which have no net charge protrude only ~ 
0.7-1.1 nm above non-rafts regions in the bilayers. The electro-osmotic flow, thus, 
should have little effect on rafts that are present in bilayers.  
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After electro-separation was complete, biotinylated lipid molecules in bilayers 
were stained to make them visible using Alexa Fluor-594 labeled streptavidin (0.5 μM). 
Streptavidin is known to bind biotin molecules with a high binding affinity.179  
The results in Figure 4.6 show that band separation depends on the size of rafts in 
the bilayers employed. Although the surface density of rafts was changed as well, the 
difference in size was more pronounced (see Table 5.1). Thus, the results will be 
described according to the size of rafts rather than the surface density. It was assumed 
that the lipid composition is independent of the size of rafts. The microrafts (7-11 µm)-
containing bilayers showed substantial band broadening after 30 minutes of applied 
voltage. In fact, only one band was found (resolution, Rs = 0). The effect of surface 
roughness due to HF-etching on electrophoresis was found to be negligible. In contrast, 
bilayers containing 2 µm-sized rafts showed decreased band broadening and had a 
resolution (Rs) of 0.6. However, it should be noted that this result was reproduced poorly 
from batch to batch. This is probably due to the low reproducibility of raft formation as 
described above. 
As the size of rafts decreased to the nanometer range, the separation of the two 
bands was significantly improved. The bands were resolved into two distinct 
chromatographic features with the value of Rs = 1.0 for 98 nm-sized nanorafts. The two 
bands were further resolved with the value of Rs = 1.5 in the bilayers containing 42 nm-
sized nanorafts. Further decrease in the size of nanorafts showed no improvements in the 
resolution (data not shown).  
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Figure 4.6.  Electro-separation of biotin-DPPE and biotin-DOPE using variously-sized 
rafts-containing supported lipid bilayers as matrix. (a) 11 μm, (b) 7 μm, (c) 2 μm, (d) 98 
nm, (e) 42 nm, and (f) no observable rafts. The fluorescence micrographs inside panels 
show band migration after applying 125 V/cm (DC) across the sample for 30 minutes. 
The small peak to the left in each image indicates the initial thin bilayer strip. The line 
scans (from white dotted line in fluorescence micrographs) have been corrected for 
vignetting and normalized to the fluorescence level of the initial peak. Each peak (red 
dots) from line profiles was baseline-resolved using a standard Guassian function (blue 
lines), resulting in band resolution (Rs) as depicted in each panel. 
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 In order to characterize the two bands observed, biotin-DPPE and biotin-DOPE 
with the ratio of 1:2 (mol %) were used as analytes in the presence of 42 nm-sized 
nanorafts.  The quantitative comparison of the area of the two analyte peaks showed that 
the ratio of the first and second band was approximately 1:2, indicating that the first 
band corresponds to biotin-DPPE and second to biotin-DOPE.  
Finally, electrophoretic mobilities (μi) of the two biotin lipids were measured.180  
Each biotinylated lipid component (1 mol %) was exposed to lipid bilayers containing no 
rafts to large microrafts. Electrophoresis was performed as described in the experimental 
section to measure the electrophoretic mobilities. Only one band was found for all 
conditions as expected. The obtained values of μi are summarized in Table 5.2. In fact, 
the values of μi for both lipids were found to be similar either in microrafts or no raft-
containing bilayers. However, the μi values were different in nanoraft-containing 
bilayers: 4.1 (± 0.5) × 105 μm2/(V·min) for biotin-DOPE and 2.4 (± 0.6) × 105 
μm2/(V·min) for biotin-DPPE, respectively. These results suggest that the 
electrophoretic mobilitiy of biotin-DPPE slows down more than that of biotin-DOPE in 
the presence of nanorafts-containing lipid bilayers. 
Partition coefficients (Kpi) of biotin-DPPE and biotin-DOPE. The two biotin 
lipids could have different partitioning preferences of their anchors into raft and non-raft 
regions. To investigate partitioning properties, partition coefficients (Kpi) for biotin-
DPPE and biotin-DOPE were experimentally determined by comparing average 
fluorescence intensities of areas corresponding to raft and non-raft regions in the 
presence of two biotin lipids. It should be noted that fluorescence intensity is only  
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Table 5.2.  Comparison of electrophoretic mobilities (μi) 
*Electrophoretic mobilities (μi, ×105 μm2/(V·min))  
Biotin-DPPE Biotin-DOPE 
No rafts - 4.4 ± 0.5 - 4.8 ± 0.5 
Nanorafts (42 nm) - 2.4 ± 0.6 - 4.1 ± 0.5 
Microrafts (11 μm) - 4.0 ± 0.6 - 4.1 ± 0.5 
*Electrophoretic mobility (μi) was calculated with following equation:  
E
Ui
i =μ   
where U is the migration distance per time (μm/min) and E = 125 V/cm.  
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dependent on the immediate environment of the probe, and insensitive to the raft size to 
estimate partition coefficients.181 Thus, one partition coefficient from a certain size of 
rafts will represent all cases in these experiments. The resulting fluorescence 
micrographs and partition coefficient (Kpi) are shown in Figure 4.7. In this case, the raft 
regions appear bright. Estimates from fluorescence micrographs resulted in a partition 
coefficient for biotin-DPPE with the value of Kp1 ~ 1.6, indicating that biotin-DPPE 
preferentially partitions to a detectable, albeit modest, extent into the raft regions. This is 
consistent with the notion that saturated fatty acyl chains partition preferentially into the 
less fluid membrane in the rafts.182 In contrast, biotin-DOPE exhibits apparently no 
preference to partition into any regions in the bilayers, with Kp2 value of ~ 1.0. 
Not only does biotin-DPPE partition with ~ 1.6 times higher preference into raft 
regions than biotin-DOPE, but also biotin-DPPE molecules show slower electrophoretic 
mobility (μi) only in the matrix lipid bilayers containing nanorafts. This is consistent 
with previously reported observations that small obstacles are more efficient than larger 
obstacles at hindering diffusion.183 In addition, nanorafts were usually formed with 
higher surface densities than microrafts in this study. Therefore, we suggest that the 
biotin-DPPE lipid molecules should encounter and interact with rafts more frequently in 
nanorafts-containing bilayers than biotin-DOPE. Thus, biotin-DPPE molecules will tend 
to remain in the nanoraft regions, and move more slowly toward the positive electrode. 
Various-sized rafts are reminiscent of particles of different size in column 
chromatography, i.e. liquid chromatography (LC). Thus, it may be useful to relate the 
band resolution (Rs) obtained herein to the conventional column chromatography  
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Figure 4.7.  Estimation of partition coefficients (Kpi) for each biotin lipids between raft 
and non-raft regions. (a) and (b) fluorescence images for biotin-DPPE and biotin-DOPE 
in rafts (7 μm), respectively. 40× objective was used for images. The black lines in the 
images are scratches that were intentionally made with a pair of metal tweezers for the 
estimation of the background contribution to the measured fluorescence intensity. (c) 
and (d) corresponding line scans from red dotted lines in (a) and (b). Kpi was estimated 
from the background-corrected average fluorescence intensities of raft and non-raft 
regions in the images of the planar bilayers.  
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resolution equation.174 It must be noted that this comparison is not completely accurate, 
as instead of a stationary phase and a mobile phase there are two phases with somewhat 
different mobilities. Nevertheless, the broad principles are similar enough that additional 
insight can be obtained. The ratio of surface areas (Snr/Sr) of non-raft and raft regions in 
bilayers employed can be correlated to the volume ratio (Vm/Vs) of mobile and stationary 
phases in LC, accordingly. This simple approximation could lead us to roughly estimate 
resolution values, which are shown in Table 1.1. The experimentally determined values 
of Rs (obtained) in bilayers electrophoresis were comparable with the calculated values 
of Rs (expected). However, further experiments and careful analysis should be required 
for detailed discussion, which is beyond this paper.   
 
Conclusion 
This work reports bilayer electrophoresis using rafts of varying size as the 
separation media. Specifically, the electro-separation of two biotin lipid molecules with 
different anchors was demonstrated in the presence of variously-sized rafts on solid 
supported lipid bilayers. The results showed that the band resolution depends on the size 
of rafts in the bilayers. In particular, nanorafts-containing bilayers showed enhanced 
band separation with greatly reduced band widths. We suggest that the difference in 
partitioning of lipid anchors between raft and non-raft regions in bilayers could affect the 
electro-separation.  Namely, lipids with doubly saturated acyl chains (biotin-DPPE) have 
a stronger interaction with the raft regions (Kp1 ~ 1.6). In contrast, lipids with doubly 
unsaturated acyl chains (biotin-DOPE) have no preference for raft regions (Kp2 ~ 1.0).  
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Indeed, biotin-DPPE lipids showed slower electrophoretic mobility than biotin-
DOPE in the presence of nanorafts. These results suggest the possibility that the 
resolution of membrane-anchored protein separation using electrophoresis with 
supported bilayers can be improved by using raft-containing bilayers as demonstrated 
here. Finally, recent studies have proposed that the size of cell membrane rafts are likely 
to be less than 70 nm in diameter.184 This corresponds with the size of rafts that allowed 
the two biotin molecules to be successfully separated by bilayer electrophoresis in our 
work. We hope our results could suggest some ideas to the current biological studies 
related to the rafts.   
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CHAPTER VI  
CONCLUSION  
 
Fluid supported lipid bilayers provide an excellent platform for studying 
multivalent protein-ligand interactions because the two-dimensional fluidity of the 
membrane allows for the lateral rearrangement of ligands to optimize binding. Our 
laboratory has combined supported lipid bilayer-coated microfluidic platforms with total 
internal reflection fluorescence microscopy (TIRFM) to obtain equilibrium dissociation 
constant (KD) data for these systems. This high throughput, on-chip approach provides 
highly accurate thermodynamic information about multivalent binding events while 
requiring only very small sample volumes.  
From these studies, we reported the effects of ligand presentation on the binding 
of aqueous proteins to solid supported lipid bilayers. Specifically, we showed that the 
equilibrium dissociation constant can be strongly affected by ligand lipophilicity and 
linker length/structure. The apparent equilibrium dissociation constants (KD) were 
compared for two model systems, biotin/anti-biotin and 2,4-dinitrophenyl (DNP)/anti-
DNP, in bulk solution and at model membrane surfaces. The binding constants in 
solution were obtained from fluorescence anisotropy measurements. The surface binding 
constants were determined by microfluidic techniques in conjunction with total internal 
reflection fluorescence microscopy. The results showed that the bulk solution 
equilibrium dissociation constants for anti-biotin and anti-DNP were almost identical, 
KD(bulk) = 1.7 ± 0.2 nM vs. 2.9 ± 0.1 nM. By contrast, the dissociation constant for anti-
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biotin antibody was three orders of magnitude tighter than for anti-DNP at a lipid 
membrane interface, KD = 3.6 ± 1.1 nM vs. 2.0 ± 0.2 µM. We postulate that the 
pronounced difference in surface binding constants for these two similar antibodies is 
due to differences in the ligands’ relative lipophilicity. Namely, the more hydrophobic 
DNP molecules had a stronger interaction with the lipid bilayers, rendering them less 
available to incoming anti-DNP antibodies compared with the biotin/anti-biotin system. 
However, when membrane-bound biotin ligands were well screened by a poly (ethylene 
glycol) (PEG) polymer brush, the KD value for the anti-biotin antibody could also be 
weakened by three orders of magnitude, 2.4 ± 1.1 µM. On the other hand, the 
dissociation constant for anti-DNP antibodies at a lipid interface could be significantly 
enhanced when DNP haptens were tethered to the end of very long hydrophilic PEG 
lipopolymers (KD = 21 ± 10 nM) rather than presented on short lipid-conjugated tethers. 
These results demonstrated that ligand presentation strongly influences protein 
interactions with membrane-bound ligands. 
Current surface binding assays routinely require fluorescently labeling the 
proteins of interest. However, protein labeling can interfere with detection measurements 
and be highly inconvenient to be employed. Herein, we described a highly sensitive 
technique for detecting protein-ligand binding at the liquid/solid interface. The method 
was based upon modulation of the interfacial pH upon protein binding. This change was 
detected by ortho-Texas Red DHPE, which was doped into supported phospholipid 
bilayers and used as a pH sensitive dye. The dye molecule fluoresces strongly at acidic 
pH values, but not basic ones and has an apparent pKA of 7.8 in 1-palmitoyl-2-oleoyl-sn-
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glycero-3-phosphocholine membranes containing 0.5 mol % biotin-cap-PE. Introducing 
a saturation concentration of anti-biotin antibodies to the system shifted the apparent 
pKA value by 0.35 pH units. The equilibrium dissociation constant of the biotin/anti-
biotin system could be determined by following the rise in fluorescence intensity at the 
interface as the antibody is introduced. This change was essentially linear with protein 
coverage under the conditions employed. Using this method, it was determined that KD = 
24 ± 5 nM for biotin/anti-biotin, which was in excellent agreement with classical 
measurements made by total internal reflection fluorescence microscopy involving 
fluorophore-conjugated antibody molecules. Moreover, the limit of detection for the 
label free method was ~8 pM anti-biotin in the bulk solution at the 99% confidence 
level. This detection limit corresponded to 380 proteins bound to the surface over a 
single 1.7 µm2 sensor element area. Such results compare extremely favorably with 
surface plasmon resonance studies of interfacial ligand-receptor binding. In fact, the 
value for the detection limit is amongst the lowest known for any technique run in 
imaging mode. Multiple assays could be performed simultaneously by imaging a parallel 
array of microfluidic channels with a CCD camera. 
Finally, electrophoresis using rafts-containing lipid bilayers on solid support as 
separation media was demonstrated. Lipid rafts of varying size were formed by a process 
which was controlled by varying the solid substrate (glass) treatment. Raft formation 
was characterized by fluorescence microscopy and atomic force microscopy (AFM). 
Depending on which method was employed, our results showed that the size of lipid 
rafts could be modulated over five orders of magnitude. Using these rafts-containing 
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bilayers as separation matrices, we separated two similar membrane-anchored lipid 
components by electrophoresis: 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-
(cap biotinyl) (biotin-DPPE) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
(cap biotinyl) (biotin-DOPE). These two lipids have the same head group and same 
charge, but differ in the structure of their lipid anchors.  It was found that the separation 
of the two components depended on the size of rafts in the bilayer matrix. In particular, 
the electrophoretic mobilities (μi) of the two components were found to differ in the 
presence of nanorafts. In addition, it is shown that the partitioning preference of biotin-
DPPE into rafts was found to be about 1.6 times higher than that of biotin-DOPE. These 
suggest that the partitioning preference of the lipid’s anchors could affect the separation 
during electrophoresis. These results indicate that the separation of lipid components and 
possibly other biological membrane components through bilayer electrophoresis can be 
improved through the use of lipid rafts. 
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